Share
Explore
Opps
Opportunities
Row
Owner Role
Opportunity Owner
Sales Manager
Account Name
Opportunity Name
Stage
Fiscal Period
Amount Currency
Amount
Expected Revenue Currency
Expected Revenue
Probability
Age
Close Date
Created Date
Next Step
Lead Source
Type
Account I D18 Digit
Ultimate Account ID
Ultimate Account ID 1
Ultimate Parent ID
Product
Product2
Product Line
Account ID
Parent Account ID
Low Usage
1
4/4/2022
US Sales User - R&D SMB
Seth Fox
David Florez
Coherus BioSciences, Inc.
Renewal 2022: Coherus Biosciences - eTMF - 10 Active / 11 Archive Sites
Closed Won
Q1-2023
100
339
4/4/2022
5/1/2021
Renewal
0015000000tq1wMAAQ
0015000000tq1wMAAQ
eTMF
Vault
R&D
0015000000tq1wM
Coherus Biosciences, Inc.
2
4/5/2022
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
Renewal 2022: Nektar - Vault Subs/Subs A - 20 Full, 14 Archive
Closed Won
Q1-2023
100
356
4/5/2022
4/15/2021
Renewal
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
Submissions
Vault
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
3
4/5/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Pharma Start, LLC
Renewal 2022: Firma Clinical - Vault eTMF - DermaSensor - 22 Sites
Closed Won
Q1-2023
100
105
4/5/2022
12/21/2021
Subscription
0012J00002K4ubFQAR
0012J00002K4ubFQAR
R&D
0012J00002K4ubF
Firma Clinical
4
4/6/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal 2022: CATO SMS - QD VT ELA 1500
Closed Won
Q1-2023
100
364
4/6/2022
4/7/2021
Renewal
0015000000htJv3AAE
0015000000htJv3AAE
QualityDocs; Vault Training
Vault
R&D
0015000000htJv3
Pharm-Olam International, LLC
5
4/7/2022
JP Sales User - R&D ENT
Junichiro Tomoda
Sumitomo Pharma Co., Ltd.
Renewal 2022: Dainippon Sumitomo Global Submission 990 users
Closed Won
Q1-2023
100
362
4/7/2022
4/11/2021
Renewal
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
Submissions
Vault
R&D
0015000000ORqoN
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
6
4/8/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2022: Checkmate Pharmaceuticals_Vault eTMF
Closed Won
Q1-2023
100
329
4/8/2022
5/14/2021
Renewal
0015000001JKFZmAAP
0015000001JKFZmAAP
eTMF
Vault
R&D
0015000001JKFZm
Checkmate Pharmaceuticals, Inc.
7
4/11/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2022: Checkmate Pharmaceuticals_Vault Quality (QDocs & Training)
Closed Won
Q1-2023
100
285
4/11/2022
7/1/2021
Renewal
0015000001JKFZmAAP
0015000001JKFZmAAP
QualityDocs; Vault Training
Vault
R&D
0015000001JKFZm
Checkmate Pharmaceuticals, Inc.
8
4/12/2022
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
Protara Therapeutics, Inc.
Renewal 2022: Protara eTMF archive 43 sites 11 active
Closed Won
Q1-2023
100
357
4/12/2022
4/20/2021
Renewal
0012J00002N3aodQAB
0012J00002N3aodQAB
eTMF
Vault
R&D
0012J00002N3aod
Protara Therapeutics
9
4/12/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Intarcia Therapeutics, Inc.
Renewal 2022: Intarcia Therapeutics_Veeva QualityDocs Superseding Licensing Extension April 2022
Closed Won
Q1-2023
100
71
4/12/2022
1/31/2022
Subscription
0015000001IfBXpAAN
0015000001IfBXpAAN
R&D
0015000001IfBXp
Intarcia Therapeutics, Inc.
10
4/15/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Parker Institute for Cancer Immunotherapy
Renewal 2022: Parker Institute - QualityDocs_200 ELA & 33 eTMF- Safety
Closed Won
Q1-2023
100
308
4/15/2022
6/12/2021
Renewal
0015000001EbYF8AAN
0015000001EbYF8AAN
eTMF; QualityDocs
Vault
R&D
0015000001EbYF8
Parker Institute for Cancer Immunotherapy
11
4/15/2022
EU Sales User - R&D SMB
Raminta Baskyte
Ecuphar NV
Renewal 2022: Ecuphar - Ph I - QMS
Closed Won
Q1-2023
100
394
4/15/2022
3/17/2021
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
QMS; QualityDocs
Vault
R&D
00150000019EABE
0015000001T4uzn
Ecuphar NV
12
4/15/2022
EU Sales User - R&D SMB
Raminta Baskyte
Ecuphar NV
Renewal 2022: Ecuphar - RIM - Subs, Reg & Ramp
Closed Won
Q1-2023
100
394
4/15/2022
3/17/2021
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
Registrations; Submissions
Vault
R&D
00150000019EABE
0015000001T4uzn
Ecuphar NV
13
4/15/2022
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2022: Abbott Vascular LATAM/CALA
Closed Won
Q1-2023
100
347
4/15/2022
5/3/2021
Renewal
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
PromoMats
Vault
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
14
4/17/2022
EU Sales User - CDMS
Greet Van Thillo
Allucent
Renewal 2022: Specialized Medical Services-oncology B.V. eTMF CTMS SSU
Closed Won
Q1-2023
100
352
4/17/2022
5/1/2021
Renewal
0015000000htJv3AAE
0015000000htJv3AAE
CTMS; eTMF
Vault
R&D
0015000000htJv3
Pharm-Olam International, LLC
15
4/20/2022
US Sales User - R&D SMB
Jared Steinberg
Jonathan Waldvogel
Angion Biomedica Corp.
Renewal 2022: Angion QualityDocs
Closed Won
Q1-2023
100
355
4/20/2022
5/1/2021
Renewal
0015000001IHjoaAAD
0015000001IHjoaAAD
QualityDocs
Vault
R&D
0015000001IHjoa
Angion Biomedica Corp.
16
4/20/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH - RIM Suite (Subs, SubsA, Pub)
Closed Won
Q1-2023
100
345
4/20/2022
5/10/2021
Renewal
00150000014RszdAAC
00150000014RszdAAC
Submissions; Submissions Archive; Submissions Publishing
Vault
R&D
00150000014Rszd
St. Jude Children's Research Hospital
17
4/20/2022
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET QualityDocs - JP/US/EU
Closed Won
Q1-2023
100
294
4/20/2022
7/1/2021
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
QualityDocs
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
18
4/22/2022
EU Sales User - CDMS
Sam Rolfe
Exom Group Srl
Renewal 2022: Exom - eTMF - 162 sites - June to Aug -3 months
Closed Won
Q1-2023
100
87
4/22/2022
1/25/2022
Sales
Subscription
0015000000tptQnAAI
0015000000tptQnAAI
R&D
0015000000tptQn
Exom Group
19
4/26/2022
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore_Vault Submissions/Submissions Archive
Closed Won
Q1-2023
100
358
4/26/2022
5/3/2021
Sales
Renewal
0012J00002LO4EvQAL
0012J00002LO4EvQAL
Submissions; Submissions Archive
Vault
R&D
0012J00002LO4Ev
Immunocore, Ltd
20
4/27/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Cullinan Oncology
Renewal 2022: Cullinan Oncology - eTMF - (32)
Closed Won
Q1-2023
100
279
4/27/2022
7/23/2021
Renewal
0012J00002N4H28QAF
0012J00002N4H28QAF
eTMF
Vault
R&D
0012J00002N4H28
Cullinan Oncology
21
4/27/2022
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET eTMF ELA - JP/US/EU
Closed Won
Q1-2023
100
301
4/27/2022
7/1/2021
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
eTMF; QualityDocs; Submissions
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
22
4/27/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis Pharma AG
Renewal 2022: Sandoz Biosimilars - eTMF
Closed Won
Q1-2023
100
181
4/27/2022
10/28/2021
Sales
Subscription
0015000001280zcAAA
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0015000001280zc
001500000133m4p
The Medicines Company
23
4/28/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio RIM
Closed Won
Q1-2023
100
363
4/28/2022
5/1/2021
Renewal
0015000001S0gThAAJ
0015000001S0gThAAJ
Submissions; Submissions Archive
Vault
R&D
0015000001S0gTh
Vir Biotechnology
24
4/28/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Kiniksa Pharmaceuticals Corp.
Renewal 2022: Kiniksa- RIM
Closed Won
Q1-2023
100
360
4/28/2022
5/3/2021
Renewal
0015000001HfFYcAAN
0015000001HfFYcAAN
Submissions; Submissions Archive
Vault
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
25
4/28/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio QualityDocs & Training
Closed Won
Q1-2023
100
13
4/28/2022
4/15/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
26
4/29/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Sumitovant Biopharma, Inc.
Renewal 2022: Sumitovant Biopharma - Vault QualityDocs & Training
Closed Won
Q1-2023
100
373
4/29/2022
4/21/2021
Renewal
0012J00002OfD5XQAV
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
QualityDocs; Vault Training
Vault
R&D
0012J00002OfD5X
0012J00002MKw1c
SUMITOMO DAINIPPON PHARMA CO., LTD.
27
5/2/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio QMS - 100 Users
Closed Won
Q2-2023
100
17
5/2/2022
4/15/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
28
5/4/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon eTMF
Closed Won
Q2-2023
100
328
5/4/2022
6/10/2021
Renewal
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
eTMF
Vault
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
29
5/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - 1109
Closed Won
Q2-2023
100
135
5/4/2022
12/20/2021
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
30
5/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - Orphan 1126 & 1108
Closed Won
Q2-2023
100
9
5/4/2022
4/25/2022
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
31
5/5/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
Alimera Sciences, Inc.
Renewal 2022: Alimera RIM + QualityDocs ELA
Closed Won
Q2-2023
100
296
5/5/2022
7/13/2021
Renewal
0015000000QYShhAAH
0015000000QYShhAAH
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000QYShh
Alimera Sciences, Inc.
32
5/5/2022
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2022: Supernus Pharma - Vault eTMF, eTMF Archive, CTMS, & Payments
Closed Won
Q2-2023
100
149
5/5/2022
12/7/2021
Sales
Subscription
0015000000PiLnMAAV
0015000000PiLnMAAV
R&D
0015000000PiLnM
Supernus Pharmaceuticals, Inc.
33
5/5/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - 1212
Closed Won
Q2-2023
100
10
5/5/2022
4/25/2022
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
34
5/9/2022
EU Sales User - R&D SMB
Reto Flury
Auregen BioTherapeutics SA
Renewal 2022: Auregen Biotherapeutics- Quality
Closed Won
Q2-2023
100
304
5/9/2022
7/9/2021
Renewal
0015000001XsdfDAAR
0015000001XsdfDAAR
QualityDocs
Vault
R&D
0015000001XsdfD
Auregen Biotherapeutics SA
35
5/10/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - Valneva 4 Sites
Closed Won
Q2-2023
100
89
5/10/2022
2/10/2022
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
36
5/10/2022
EU Sales User - R&D ENT
Katrien Mesotten
Kiadis Pharma Netherlands BV
Renewal 2022: Kiadis Pharma Netherlands BV - eTMF 33 sites - year 3- 3 months
Closed Won
Q2-2023
100
375
5/10/2022
5/1/2021
Renewal
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
eTMF
Vault
R&D
00150000010hIes
0015000001TVjdf
Bioverativ, Inc.
37
5/10/2022
EU Sales User - R&D ENT
Katrien Mesotten
Kiadis Pharma Netherlands BV
Renewal 2022: Kiadis Pharma - ELA 200 QD & 45 users QMS
Closed Won
Q2-2023
100
375
5/10/2022
5/1/2021
Renewal
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QMS; QualityDocs
Vault
R&D
00150000010hIes
0015000001TVjdf
Bioverativ, Inc.
38
5/12/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2022: Omeros - Sub/SubA - 10 Full, 10 Archive
Closed Won
Q2-2023
100
370
5/12/2022
5/7/2021
Renewal
0015000000aQgjUAAS
0015000000aQgjUAAS
Submissions
Vault
R&D
0015000000aQgjU
Omeros Corporation
39
5/12/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2022: Omeros Vault QualityDocs - 300 ELA
Closed Won
Q2-2023
100
363
5/12/2022
5/15/2021
Renewal
0015000000aQgjUAAS
0015000000aQgjUAAS
QualityDocs
Vault
R&D
0015000000aQgjU
Omeros Corporation
40
5/12/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2022: Omeros - QMS - 50 Full Users + 15 in future bucket
Closed Won
Q2-2023
100
437
5/12/2022
3/1/2021
Renewal
0015000000aQgjUAAS
0015000000aQgjUAAS
QMS
Vault
R&D
0015000000aQgjU
Omeros Corporation
41
5/13/2022
US Sales User - R&D SMB
Adam Sybrowsky
David Florez
Societal CDMO
Renewal 2022: Societal CDMO QualityDocs Renewal
Closed Won
Q2-2023
100
329
5/13/2022
6/19/2021
Renewal
0015000001P4J8XAAV
0015000001P4J8XAAV
QualityDocs
Vault
R&D
0015000001P4J8X
Societal CDMO
42
5/13/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
100
78
5/13/2022
2/24/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
43
5/17/2022
EU Sales User - R&D SMB
Raminta Baskyte
Laboratorios Hipra, S.A.
Hipra - Reg,Sub - Year 2 Renewal June 2022
Closed Won
Q2-2023
100
802
5/17/2022
3/6/2020
Sales
Subscription
0015000001EeMYvAAN
0015000001EeMYvAAN
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000001EeMYv
Laboratorios Hipra
44
5/20/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Spaulding Clinical Research, LLC
Renewal 2022: Spaulding Clinical Research - eTMF
Closed Won
Q2-2023
100
371
5/20/2022
5/15/2021
Renewal
00150000015LXQaAAO
00150000015LXQaAAO
eTMF
Vault
R&D
00150000015LXQa
Spaulding Clinical Research, LLC
45
5/20/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group eTMF Full Account Renewal 6/1/2022
Closed Won
Q2-2023
100
95
5/20/2022
2/14/2022
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
46
5/20/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group - CTMS
Closed Won
Q2-2023
100
95
5/20/2022
2/14/2022
Sales
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
47
5/23/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Bellicum Pharmaceuticals Inc.
Renewal 2022: Bellicum Vault- Qdocs & eTMF
Closed Won
Q2-2023
100
355
5/23/2022
6/2/2021
Renewal
0015000000bhOLMAA2
0015000000bhOLMAA2
Submissions; Submissions Archive
Vault
R&D
0015000000bhOLM
Bellicum Pharmaceuticals, Inc.
48
5/23/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Paragon Bioteck, Inc.
Renewal 2022: Paragon Bioteck, Vault Submissions and SubmissionsArchive
Closed Won
Q2-2023
100
301
5/23/2022
7/26/2021
Renewal
0015000001KNAOJAA5
0015000001Dqpq2AAB
0015000001Dqpq2AAB
0015000001Dqpq2AAB
Submissions; Submissions Archive
Vault
R&D
0015000001KNAOJ
0015000001Dqpq2
Paragon Bioteck, Inc.
49
5/24/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2022: G1-Sub-Quality-QMS-eTMF-Training- Platform
Closed Won
Q2-2023
100
385
5/24/2022
5/4/2021
Renewal
00150000019CZTNAA4
00150000019CZTNAA4
QualityDocs
Vault
R&D
00150000019CZTN
G1 Therapeutics, Inc.
50
5/24/2022
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2022: BIKEN QualityDocs
Closed Won
Q2-2023
100
363
5/24/2022
5/26/2021
Renewal
0015000001nyfi1AAA
0015000001nyfi1AAA
QualityDocs
Vault
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
51
5/24/2022
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2022: BIKEN eTMF 43 Sites
Closed Won
Q2-2023
100
358
5/24/2022
6/1/2021
Renewal
0015000001nyfi1AAA
0015000001nyfi1AAA
eTMF
Vault
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
52
5/26/2022
US Sales User - MedTech ENT
Casey Davidson
International Partnership for Microbicides, Inc.
Renewal 2022: IPM - eTMF - 30 Sites
Closed Won
Q2-2023
100
358
5/26/2022
6/2/2021
Sales
Renewal
0015000001RFZmPAAX
0015000001RFZmPAAX
eTMF
Vault
R&D
0015000001RFZmP
International Partnership for Microbicides
53
5/26/2022
US Sales User - MedTech SMB
Carla Foley
New Erie Scientific LLC
Renewal: Epredia RIM and Submissions for June 2021 through 5/31/22
Closed Won
Q2-2023
100
0
5/26/2022
5/26/2022
Sales
Subscription
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
54
5/27/2022
US Sales User - R&D SMB
Marta Considine
Adam De Oliveira
Avalo Therapeutics, Inc.
Renewal 2022: Avalo - Quality & RIM
Closed Won
Q2-2023
100
260
5/27/2022
9/9/2021
Renewal
0015000000htJuFAAU
0015000000htJuFAAU
QualityDocs; Vault Training
Vault
R&D
0015000000htJuF
Cerecor
55
5/27/2022
US Sales User - R&D ENT
Greg Boudreau
Takeda Development Center Americas, Inc.
Takeda Pharma - CTMS_SSU_Payments_Site Connect - Global - ELA Year 1
Closed Won
Q2-2023
100
120
5/27/2022
1/27/2022
Sales
Subscription
0012J00002aXg5vQAC
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002aXg5v
0012J00002MJsv2
Shire Pharmaceuticals Inc.
56
5/31/2022
US Sales User - MedTech ENT
Jeff Wheeler
New Erie Scientific LLC
Epredia RIM and Submissions for June 2022 through 5/31/23
Closed Won
Q2-2023
100
722
5/31/2022
6/8/2020
Renewal
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
Submissions; Submissions Archive
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
57
5/31/2022
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
Renewal 2022: Nektar Vault eTMF - 401 Active, 65 Archive
Closed Won
Q2-2023
100
350
5/31/2022
6/15/2021
Renewal
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
eTMF
Vault
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
58
5/31/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2022: Syneos eTMF - 3YR ELA - (Year 2)
Closed Won
Q2-2023
100
335
5/31/2022
6/30/2021
Renewal
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
eTMF
Vault
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
59
6/1/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Prolong Pharmaceuticals, LLC
Renewal 2022: Prolong - Vault QualityDocs,QMS
Closed Won
Q2-2023
100
393
6/1/2022
5/4/2021
Renewal
0015000000bhOKvAAM
0015000000bhOKvAAM
QualityDocs
Vault
R&D
0015000000bhOKv
Prolong Pharmaceuticals, LLC
60
6/1/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI eTMF 6-1-2022
Closed Won
Q2-2023
100
169
6/1/2022
12/14/2021
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
61
6/2/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Arvinas Operations, Inc
Renewal 2022: Arvinas - QDocs & Training & Subs/SubsA
Closed Won
Q2-2023
100
336
6/2/2022
7/1/2021
Renewal
0015000001MaGUTAA3
0015000001MaGUTAA3
QualityDocs; Vault Training
Vault
R&D
0015000001MaGUT
Arvinas
62
6/2/2022
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2023: Dizal-China Biotech-QD+TRN-ELA250
Closed Won
Q2-2023
100
0
6/2/2022
6/2/2022
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
63
6/2/2022
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2024: Dizal-China Biotech-QD+TRN-ELA250
Closed Won
Q2-2023
100
0
6/2/2022
6/2/2022
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
64
6/6/2022
US Sales User - R&D SMB
Seth Fox
David Florez
Coherus BioSciences, Inc.
Renewal 2022: Coherus - RIM (Subs/SubsA)
Closed Won
Q2-2023
100
102
6/6/2022
2/24/2022
Subscription
0015000000tq1wMAAQ
0015000000tq1wMAAQ
R&D
0015000000tq1wM
Coherus Biosciences, Inc.
65
6/9/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1154
Closed Won
Q2-2023
100
171
6/9/2022
12/20/2021
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
66
6/9/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1082
Closed Won
Q2-2023
100
7
6/9/2022
6/2/2022
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
67
6/9/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1166
Closed Won
Q2-2023
100
7
6/9/2022
6/2/2022
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
68
6/9/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
GSK Consumer Vault QMS P3 Renewal
Closed Won
Q2-2023
100
699
6/9/2022
7/10/2020
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
QMS
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
69
6/16/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
100
34
6/16/2022
5/13/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
70
6/17/2022
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET Subs ELA & Subs Archive 6th Year - JP/US
Closed Won
Q2-2023
100
353
6/17/2022
6/29/2021
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
eTMF; QualityDocs; Submissions
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
71
6/19/2022
EU Sales User - R&D SMB
Jeremy Cottin
ERYTECH Pharma S.A
Renewal 2022: Erytech - QMS - ELA300- Year 1 + ramp
Closed Won
Q2-2023
100
376
6/19/2022
6/8/2021
Sales
Subscription
00150000019s0WQAAY
00150000019s0WQAAY
QMS
Vault
R&D
00150000019s0WQ
Erytech
72
6/21/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma QualityDocs ELA
Closed Won
Q2-2023
100
147
6/21/2022
1/25/2022
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
73
6/22/2022
US Sales User - R&D SMB
Emily Rollet
Ernie Chin
Purdue Pharma L.P.
Renewal 2022: Purdue/Imbrium - Vault Submissions - 60 users
Closed Won
Q2-2023
100
326
6/22/2022
8/1/2021
Renewal
0015000000IO284AAD
0015000000IO284AAD
Submissions
Vault
R&D
0015000000IO284
Purdue Pharma L.P.
74
6/22/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2022: G1 Therapeutics - Safety (4 month renewal)
Closed Won
Q2-2023
100
104
6/22/2022
3/10/2022
Sales
Subscription
00150000019CZTNAA4
00150000019CZTNAA4
R&D
00150000019CZTN
G1 Therapeutics, Inc.
75
6/22/2022
EU Sales User - CDMS
Greet Van Thillo
European Organisation for Research and Treatment of Cancer
Renewal 2022: EORTC QMS ELA 300
Closed Won
Q2-2023
100
295
6/22/2022
9/1/2021
Renewal
0015000000wyMo2AAE
0015000000wyMo2AAE
QMS
Vault
R&D
0015000000wyMo2
EORTC
76
6/23/2022
US Sales User - MedTech ENT
Alyssa Martucci
New Erie Scientific LLC
Renewal: Epredia Vault Qdocs_ Runcorn 50 Full Users term 3
Closed Won
Q2-2023
100
507
6/23/2022
2/1/2021
Sales
Subscription
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
QualityDocs
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
77
6/27/2022
US Sales User - R&D SMB
Julie Bolger
Ernie Chin
Amarin Pharma Inc.
Renewal 2022: Amarin Corp_Vault Submissions/Submissions Archive
Closed Won
Q2-2023
100
317
6/27/2022
8/15/2021
Renewal
0015000000UlZyYAAV
0015000000MMajDAAT
0015000000MMajDAAT
0015000000MMajDAAT
Submissions; Submissions Archive
Vault
R&D
0015000000UlZyY
0015000000MMajD
Amarin Corporation (US Headquarters)
78
6/28/2022
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Jul 2024: Medytox_KR_QMS_ELA500_Year3
Closed Won
Q2-2023
100
1
6/28/2022
6/27/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
79
6/30/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma RIM Suite Y3 Renewal (EU)
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
80
6/30/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma PT - Vault QMS - EU-Yr 3 Renewal
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
81
6/30/2022
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma RIM Suite Yr 3 Renewal (US)
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
82
6/30/2022
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma PT - Vault QMS - US-Yr 3 Renewal
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
83
7/1/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Turning Point Therapeutics - QualityDocs and Training - ELA 300 (Ramp Yr. 1, Period 2)
Closed Won
Q2-2023
100
164
7/1/2022
1/18/2022
Sales
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
84
7/1/2022
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma Publishing-US/EU-Yr 1 Renewal
Closed Won
Q2-2023
100
277
7/1/2022
9/27/2021
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Submissions Publishing
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
85
7/1/2022
US Sales User - MedTech ENT
Bryan Federici
Foundation Medicine, Inc.
FMI Year 2 ELA for QMS & QDocs
Closed Won
Q2-2023
100
317
7/1/2022
8/18/2021
Sales
Subscription
0015000000ddJezAAE
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS; QualityDocs
Vault
R&D
0015000000ddJez
0012J00002ZERRv
Chugai Pharmaceutical Co.,Ltd.
86
7/3/2022
Asia Pac Sales User - R&D ENT
Amber Lee
SillaJen, Inc.
Renewal 2022: Sillajen - Vault QualityDocs - 50 Employee ELA
Closed Won
Q2-2023
100
368
7/3/2022
7/1/2021
Renewal
0015000002GVFnkAAH
0015000002GVFnkAAH
QualityDocs
Vault
R&D
0015000002GVFnk
Sillajen Biotherapeutics, Inc.
87
7/3/2022
Asia Pac Sales User - R&D ENT
Amber Lee
SillaJen, Inc.
Renewal 2022: Sillajen - Vault eTMF & CTMS
Closed Won
Q2-2023
100
337
7/3/2022
8/1/2021
Renewal
0015000002GVFnkAAH
0015000002GVFnkAAH
eTMF
Vault
R&D
0015000002GVFnk
Sillajen Biotherapeutics, Inc.
88
7/6/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
GW Research Limited
Renewal 2022: GW eTMF
Closed Won
Q2-2023
100
389
7/6/2022
6/13/2021
Renewal
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
eTMF
Vault
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
89
7/6/2022
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology RIM
Closed Won
Q2-2023
100
363
7/6/2022
7/9/2021
Renewal
0015000001XrfCWAAZ
0015000001XrfCWAAZ
Submissions; Submissions Archive
Vault
R&D
0015000001XrfCW
Homology Medicines Inc.
90
7/6/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Kiniksa Pharmaceuticals Corp.
Renewal 2022: Kiniksa Pharmaceuticals - eTMF
Closed Won
Q2-2023
100
335
7/6/2022
8/5/2021
Renewal
0015000001HfFYcAAN
0015000001HfFYcAAN
eTMF
Vault
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
91
7/7/2022
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology Medicines - Quality & Training ELA 200 #NC
Closed Won
Q2-2023
100
364
7/7/2022
7/9/2021
Renewal
0015000001XrfCWAAZ
0015000001XrfCWAAZ
QualityDocs; Station Manager
Vault
R&D
0015000001XrfCW
Homology Medicines Inc.
92
7/8/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2022: Tesaro GSK QMS 3 months
Closed Won
Q2-2023
100
233
7/8/2022
11/17/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
93
7/11/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Jul 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
100
25
7/11/2022
6/16/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
94
7/11/2022
JP Sales User - R&D ENT
Junichiro Tomoda
Sumitomo Pharma Co., Ltd.
Renewal 2022: SMP Clinical QMS 25 users
Closed Won
Q2-2023
100
345
7/11/2022
8/1/2021
Renewal
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
QMS
Vault
R&D
0015000000ORqoN
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
95
7/12/2022
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
2024 Renewal: Sanofi - QDocs QMS Training ELA
Closed Won
Q2-2023
100
368
7/12/2022
7/9/2021
Renewal
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QualityDocs
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
96
7/12/2022
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
2023 Renewal: Sanofi - QDocs QMS Training ELA
Closed Won
Q2-2023
100
1596
7/12/2022
2/27/2018
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QualityDocs
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
97
7/13/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedx - Vault eTMF, CTMS, & Payments
Closed Won
Q2-2023
100
345
7/13/2022
8/2/2021
Renewal
0015000001EIny5AAD
0015000001EIny5AAD
Submissions; Submissions Archive
Vault
R&D
0015000001EIny5
Mimedx Group
98
7/13/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedx - Submissions and Submissions Archive
Closed Won
Q2-2023
100
89
7/13/2022
4/15/2022
Subscription
0015000001EIny5AAD
0015000001EIny5AAD
R&D
0015000001EIny5
Mimedx Group
99
7/14/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
TherapeuticsMD, Inc.
TherapeuticsMD New SubmissionsArchive - 4Month renewal
Closed Won
Q2-2023
100
324
7/14/2022
8/24/2021
Sales
Subscription
0015000000dbU1sAAE
0015000000dbU1sAAE
Submissions Archive
Vault
R&D
0015000000dbU1s
TherapeuticsMD, Inc
100
7/19/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Repertoire Immune Medicines
Renewal 2022: Repertoire - eTMF #NC
Closed Won
Q2-2023
100
309
7/19/2022
9/13/2021
Renewal
0012J00002P8I3DQAV
0012J00002P8I3DQAV
eTMF
Vault
R&D
0012J00002P8I3D
Repertoire Immune Medicines
101
7/19/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI Vault Submissions 7-1-2022
Closed Won
Q2-2023
100
242
7/19/2022
11/19/2021
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
102
7/19/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Amylyx - QualityDocs & Training (Yr. 2)
Closed Won
Q2-2023
100
127
7/19/2022
3/14/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
103
7/20/2022
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2022: Jazz Pharmaceuticals - Vault eTMF
Closed Won
Q2-2023
100
387
7/20/2022
6/28/2021
Renewal
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
eTMF
Vault
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
104
7/20/2022
US Sales User - R&D SMB
Anthony Gotzis
J&J Pharmaceuticals
Renewal 2022: Momenta RIM, QD, QMS, Training ELA200
Closed Won
Q2-2023
100
113
7/20/2022
3/29/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
105
7/20/2022
LatAm Sales User
Luis Fernandez
Específicos Stendhal S.A de C.V.
Renewal 2022: Stendhal LatAm Registrations 10 Users
Closed Won
Q2-2023
100
415
7/20/2022
6/1/2021
Renewal
0015000000fTHSgAAO
0012J00002K4P7SQAV
0012J00002K4P7SQAV
0012J00002K4P7SQAV
Registrations; Submissions
Vault
R&D
0015000000fTHSg
0012J00002K4P7S
Espec�ficos Stendhal S.A de C.V.
106
7/21/2022
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal 2022: IAVI - NA - eTMF
Closed Won
Q2-2023
100
97
7/21/2022
4/15/2022
Subscription
00150000019DKfQAAW
00150000019DKfQAAW
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
107
7/22/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Sorrento Therapeutics, Inc.
Renewal 2022: Sorrento Therapeutics - Vault Submissions/Submissions Archive
Closed Won
Q2-2023
100
377
7/22/2022
7/11/2021
Renewal
00150000013SNjAAAW
00150000013SNjAAAW
Registrations; Submissions
Vault
R&D
00150000013SNjA
Sorrento Therapeutics, Inc.
108
7/22/2022
EU Sales User - CDMS
Sam Rolfe
Exom Group Srl
Renewal 2022: Exom - eTMF - 162 sites - Sept -Nov 3 months
Closed Won
Q2-2023
100
91
7/22/2022
4/22/2022
Sales
Subscription
0015000000tptQnAAI
0015000000tptQnAAI
R&D
0015000000tptQn
Exom Group
109
7/28/2022
US Sales User - R&D ENT
Samantha Sykora
Audentes Therapeutics, Inc.
Renewal 2022: Audentes Therapeutics-QMS-300 ELA *
Closed Won
Q2-2023
100
346
7/28/2022
8/16/2021
Renewal
0015000000sDkKcAAK
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
QMS
Vault
R&D
0015000000sDkKc
0012J00002N44Fa
Audentes Therapeutics, Inc.
110
7/29/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Strongbridge U.S. Inc.
Renewal 2022: Strongbridge Quality (QualityDocs & QMS)
Closed Won
Q2-2023
100
424
7/29/2022
6/1/2021
Renewal
00150000016BpEmAAK
00150000018Qz0AAAS
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000016BpEm
00150000018Qz0A
Strongbridge Biopharma plc
111
7/29/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati Rare Diseases, Inc.
Renewal 2022: Recordati US- Vault Training - 153 users
Closed Won
Q2-2023
100
365
7/29/2022
7/29/2021
Renewal
0015000000pJSINAA4
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
Vault Training
Vault
R&D
0015000000pJSIN
0015000000VSdDe
Recordati Rare Diseases, Inc.
112
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2023: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
1
8/3/2022
8/2/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
113
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2024: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
1
8/3/2022
8/2/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
114
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2025: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
1
8/3/2022
8/2/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
115
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2026: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
0
8/3/2022
8/3/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
116
8/5/2022
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology eTMF
Closed Won
Q3-2023
100
393
8/5/2022
7/9/2021
Renewal
0015000001XrfCWAAZ
0015000001XrfCWAAZ
eTMF
Vault
R&D
0015000001XrfCW
Homology Medicines Inc.
117
8/10/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Nevakar, Inc.
Renewal 2022: Nevakar - Vault RIM
Closed Won
Q3-2023
100
309
8/10/2022
10/5/2021
Renewal
0015000001TU8VKAA1
0015000001TU8VKAA1
Submissions; Submissions Archive
Vault
R&D
0015000001TU8VK
Nevakar, inc.
118
8/10/2022
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
Denovo Biopharma LLC
Renewal 2022: Denovo (formerly Tocagen) eTMF, Sub & Archive
Closed Won
Q3-2023
100
400
8/10/2022
7/6/2021
Renewal
00150000025afp4AAA
00150000025afp4AAA
eTMF; QualityDocs; Submissions
Vault
R&D
00150000025afp4
Denovo Biopharma LLC
119
8/16/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst Pharmaceuticals - Vault CTMS/eTMF - Orphan Sites
Closed Won
Q3-2023
100
377
8/16/2022
8/4/2021
Renewal
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
eTMF
Vault
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
120
8/16/2022
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Roche Vault Payments - Y2
Closed Won
Q3-2023
100
637
8/16/2022
11/17/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
121
8/16/2022
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Roche Vault Payments - Y3
Closed Won
Q3-2023
100
50
8/16/2022
6/27/2022
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
122
8/19/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Tiziana Life Sciences plc
Renewal 2022: Tiziana Life Sciences_Vault RIM (Submissions/Submissions Archive)
Closed Won
Q3-2023
100
324
8/19/2022
9/29/2021
Renewal
0012J00002LQ6AYQA1
0012J00002LQ6AYQA1
Submissions; Submissions Archive
Vault
R&D
0012J00002LQ6AY
Tiziana Life Sciences plc
123
8/19/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
WAVE Life Sciences Ltd.
Renewal 2022: Wave Life Sciences- Contract Management (Platform)
Closed Won
Q3-2023
100
364
8/19/2022
8/21/2021
Renewal
001500000189NO7AAM
001500000189NO7AAM
Platform R&D
Vault
R&D
001500000189NO7
Wave Life Sciences
124
8/19/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
GW Research Limited
Renewal 2022: GW Pharma QualityDocs & QMS - ELA500
Closed Won
Q3-2023
100
355
8/19/2022
8/30/2021
Renewal
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
QualityDocs
Vault
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
125
8/22/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Braeburn Inc.
Renewal 2022: Braeburn Vault Submissions/Submissions Archive
Closed Won
Q3-2023
100
342
8/22/2022
9/14/2021
Renewal
0015000000jYgnuAAC
0015000000jYgnuAAC
Submissions
Vault
R&D
0015000000jYgnu
Braeburn Inc.
126
8/22/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Roivant Sciences, Inc.
Renewal 2022: Roivant Sciences - Vault RIM, Quality, eTMF
Closed Won
Q3-2023
100
368
8/22/2022
8/19/2021
Renewal
0015000001APsQwAAL
0015000001APsQwAAL
eTMF; QMS; QualityDocs; Submissions; Submissions Archive; Vault Training
Vault
R&D
0015000001APsQw
Dermavant Sciences
127
8/22/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group - CTMS
Closed Won
Q3-2023
100
94
8/22/2022
5/20/2022
Sales
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
128
8/22/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group eTMF Full Account Renewal 9/1/2022
Closed Won
Q3-2023
100
94
8/22/2022
5/20/2022
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
129
8/22/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
GW Research Limited
Renewal 2022: GW Pharma QualityDocs 6 months courtesy for migration access
Closed Won
Q3-2023
100
31
8/22/2022
7/22/2022
Subscription
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
130
8/23/2022
US Sales User - R&D SMB
Russell Moeai
Christopher Mundy
Theravance Biopharma US, Inc.
Renewal 2022: Theravance - Subs 20 users/SubsA 10 users
Closed Won
Q3-2023
100
371
8/23/2022
8/17/2021
Sales
Renewal
0015000000LX0LMAA1
0015000000LX0LMAA1
Submissions; Submissions Archive
Vault
R&D
0015000000LX0LM
Theravance Biopharma US, Inc.
131
8/23/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2023: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
Closed Won
Q3-2023
100
0
8/23/2022
8/23/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
132
8/23/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2024: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
Closed Won
Q3-2023
100
0
8/23/2022
8/23/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
133
8/24/2022
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Vedanta Biosciences, Inc.
Renewal 2022: Vedanta - QualityDocs & Training ELA - QMS 30 Users
Closed Won
Q3-2023
100
348
8/24/2022
9/11/2021
Renewal
0015000001JGoyaAAD
0015000001JGoyaAAD
QMS; QualityDocs
Vault
R&D
0015000001JGoya
Vedanta Biosciences, Inc.
134
8/24/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
Jazz
Renewal 2022: Jazz Pharmaceuticals Vault QualityDocs and QMS ELA 3,500
Closed Won
Q3-2023
100
191
8/24/2022
2/14/2022
Sales
Subscription
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
135
8/24/2022
EU Sales User - R&D SMB
Reto Flury
Ferring International Center SA
Ferring - Vault Registrations - PUPM Year 2
Closed Won
Q3-2023
100
488
8/24/2022
4/23/2021
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
136
8/25/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2022: Arcturus Therapeutics - Vault QualityDocs & Vault Training - 200 ELA
Closed Won
Q3-2023
100
363
8/25/2022
8/27/2021
Renewal
0015000000r8H7sAAE
0015000000r8H7sAAE
QualityDocs; Vault Training
Vault
R&D
0015000000r8H7s
Arcturus Therapeutics, Inc.
137
8/25/2022
EU Sales User - R&D SMB
Sarah Kemkes
MorphoSys AG
Renewal 2022 Morphosys - RIM ELA 1000
Closed Won
Q3-2023
100
218
8/25/2022
1/19/2022
Sales
Subscription
0015000000OQ3L7AAL
0015000000OQ3L7AAL
R&D
0015000000OQ3L7
MorphoSys AG
138
8/26/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
ASH Research Collaborative
Renewal 2022: ASH - eTMF - 52 Sites
Closed Won
Q3-2023
100
346
8/26/2022
9/15/2021
Renewal
0012J00002QLRmAQAX
0012J00002QLRmAQAX
eTMF
Vault
R&D
0012J00002QLRmA
ASH Research Collaborative
139
8/28/2022
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Kodiak Sciences
Renewal 2022: Kodiak Sciences - QualityDocs - 200 ELA
Closed Won
Q3-2023
100
347
8/28/2022
9/15/2021
Renewal
0015000000bhNQvAAM
0015000000bhNQvAAM
QualityDocs
Vault
R&D
0015000000bhNQv
Kodiak Sciences
140
8/30/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon - Safety - 250 active cases
Closed Won
Q3-2023
100
350
8/30/2022
9/14/2021
Sales
Renewal
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
Vault Safety
Vault
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
141
8/30/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst - Submissions & Submissions Archive - ELA400
Closed Won
Q3-2023
100
398
8/30/2022
7/28/2021
Renewal
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
Submissions; Submissions Archive
Vault
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
142
8/30/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst Pharmaceuticals - QMS & QualityDocs - ELA400
Closed Won
Q3-2023
100
398
8/30/2022
7/28/2021
Renewal
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
QualityDocs
Vault
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
143
8/30/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark Platform Contracts Management
Closed Won
Q3-2023
100
368
8/30/2022
8/27/2021
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Platform
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
144
8/31/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Renewal - Roche Pharma eTMF/CTMS Y3 ramp (EU+US)
Closed Won
Q3-2023
100
1064
8/31/2022
10/2/2019
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
145
9/2/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - QualityDocs + Training
Closed Won
Q3-2023
100
337
9/2/2022
10/1/2021
Renewal
0015000001nxYfoAAE
0015000001nxYfoAAE
QualityDocs
Vault
R&D
0015000001nxYfo
Calico Life Sciences LLC
146
9/2/2022
EU Sales User - R&D ENT
Julien Bechtel
UCB Biopharma SRL
Renewal 2022: UCB Zogenix Legacy eTMF - $0 OF For migration
Closed Won
Q3-2023
100
110
9/2/2022
5/16/2022
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
147
9/5/2022
EU Sales User - R&D ENT
Fabian Metz
BIONTECH US INC.
Renewal 2022: BioNTech US - eTMF - migration courtesy access
Closed Won
Q3-2023
100
355
9/5/2022
9/15/2021
Renewal
0015000001HE1PXAA1
0015000001HENG5AAP
0015000001HENG5AAP
0015000001HENG5AAP
eTMF
Vault
R&D
0015000001HE1PX
0015000001HENG5
BIONTECH US INC.
148
9/6/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - eTMF Renewal
Closed Won
Q3-2023
100
336
9/6/2022
10/5/2021
Renewal
00150000018Qz0AAAS
00150000018Qz0AAAS
eTMF
Vault
R&D
00150000018Qz0A
Strongbridge Biopharma plc
149
9/6/2022
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
BioNTech SE - eTMF, CTMS, SSU- ELA Year 2
Closed Won
Q3-2023
100
81
9/6/2022
6/17/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
150
9/6/2022
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
BioNTech SE - eTMF, CTMS, SSU- ELA Year 3
Closed Won
Q3-2023
100
81
9/6/2022
6/17/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
151
9/7/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal 2022: Black Diamond Therapeutics_Vault eTMF
Closed Won
Q3-2023
100
342
9/7/2022
9/30/2021
Renewal
0015000002IiNnuAAF
0015000002IiNnuAAF
CTMS; eTMF; SiteConnect
Vault
R&D
0015000002IiNnu
Black Diamond Therapeutics
152
9/7/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark - Quality - QMS
Closed Won
Q3-2023
100
362
9/7/2022
9/10/2021
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
153
9/8/2022
EU Sales User - R&D SMB
Katrine Bødker Christensen
Calliditas Therapeutics AB
Renewal 2022: Calliditas Therapeutics AB - QD ELA 200 Subs
Closed Won
Q3-2023
100
343
9/8/2022
10/1/2021
Renewal
0015000002GUdjmAAD
0015000002GUdjmAAD
Submissions
Vault
R&D
0015000002GUdjm
Calliditas Therapeutics
154
9/12/2022
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore - Vault RIM
Closed Won
Q3-2023
100
139
9/12/2022
4/26/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
155
9/13/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH Clinical Apps
Closed Won
Q3-2023
100
397
9/13/2022
8/12/2021
Renewal
00150000014RszdAAC
00150000014RszdAAC
eTMF
Vault
R&D
00150000014Rszd
St. Jude Children's Research Hospital
156
9/14/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal May 2023: Allucent - Clinical Suite Study ELA 200
Closed Won
Q3-2023
100
0
9/14/2022
9/14/2022
Sales
Subscription
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000htJv3
Pharm-Olam International, LLC
157
9/14/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal May 2024: Allucent - Clinical Suite Study ELA 200
Closed Won
Q3-2023
100
0
9/14/2022
9/14/2022
Sales
Subscription
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000htJv3
Pharm-Olam International, LLC
158
9/16/2022
EU Sales User - R&D ENT
Julien Bechtel
Ferring International Center SA
Ferring - QualityDocs ELA Year 2 Renewal + Ramp
Closed Won
Q3-2023
100
406
9/16/2022
8/6/2021
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
QMS; QualityDocs
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
159
9/16/2022
US Sales User - R&D SMB
Justin Zaccone
Ernie Chin
Sumitomo Pharma Oncology, Inc.
Renewal 2022: SDPO- eTMF & Platform Renewal
Closed Won
Q3-2023
100
367
9/16/2022
9/15/2021
Renewal
0015000000ph6mWAAQ
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
eTMF
Vault
R&D
0015000000ph6mW
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
160
9/19/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark - NA - eTMF/CTMS Sites - ELA
Closed Won
Q3-2023
100
374
9/19/2022
9/10/2021
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
161
9/20/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
FerGene Inc.
Renewal Oct 2022: FerGene- Qdocs, Training, QMS, Subs & SubA #NC
Closed Won
Q3-2023
100
173
9/20/2022
3/31/2022
Subscription
0012J00002OdrDNQAZ
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0012J00002OdrDN
0012J00002MKF7X
FerGene
162
9/21/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal 2022: Myovant Sciences (SV) - Vault eTMF - 25 Active Sites
Closed Won
Q3-2023
100
348
9/21/2022
10/8/2021
Renewal
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
eTMF
Vault
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
163
9/22/2022
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
HilleVax, Inc.
Renewal 2022: HilleVax eTMF Archive
Closed Won
Q3-2023
100
358
9/22/2022
9/29/2021
Renewal
0012J00002U6WwuQAF
0012J00002U6WwuQAF
eTMF
Vault
R&D
0012J00002U6Wwu
HilleVax
164
9/22/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Polynoma LLC
Renewal 2022: Polynoma - Vault eTMF - 75 Active to Archive Sites
Closed Won
Q3-2023
100
118
9/22/2022
5/27/2022
Sales
Subscription
0015000000fTTJBAA4
0015000000fTTJBAA4
R&D
0015000000fTTJB
Polynoma LLC
165
9/26/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2023: Syneos - Unified Clinical - SSU, CTMS, Payments - YR2
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
166
9/26/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2024: Syneos - Unified Clinical - SSU, CTMS, Payments - YR3
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
167
9/26/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2023: EOCPharma-China-Submission&Sub Archive-15users&2users
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
168
9/26/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2024: EOCPharma-China-Submission&Sub Archive-15users&2users
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
169
9/28/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal 2022: Black Diamond_Vault RIM (Submissions/Publishing/Submissions Archive) #NC
Closed Won
Q3-2023
100
364
9/28/2022
9/29/2021
Renewal
0015000002IiNnuAAF
0015000002IiNnuAAF
Submissions; Submissions Archive
Vault
R&D
0015000002IiNnu
Black Diamond Therapeutics
170
9/28/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - Vault Sub/SubA - 10 Subs; 5 SubsA Users
Closed Won
Q3-2023
100
142
9/28/2022
5/9/2022
Sales
Subscription
0015000001nxYfoAAE
0015000001nxYfoAAE
R&D
0015000001nxYfo
Calico Life Sciences LLC
171
9/28/2022
US Sales User - R&D ENT
Jon Tenconi
Astellas Pharma US LLC
Renewal 2022: Astellas - Issue Management - Active Study License
Closed Won
Q3-2023
100
377
9/28/2022
9/16/2021
Renewal
0015000000IO270AAD
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
CTMS
Vault
R&D
0015000000IO270
0012J00002bzHrs
Audentes Therapeutics, Inc.
172
9/29/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - Submissions and Submissions Archive Renewal
Closed Won
Q3-2023
100
364
9/29/2022
10/1/2021
Renewal
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000018Qz0A
Strongbridge Biopharma plc
173
9/29/2022
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Adverum Biotechnologies, Inc.
Renewal 2022: Adverum Biotechnologies - Vault Sub/SubA - 200 ELA
Closed Won
Q3-2023
100
364
9/29/2022
10/1/2021
Renewal
0015000000wO1vGAAS
0015000000wO1vGAAS
Submissions; Submissions Archive
Vault
R&D
0015000000wO1vG
Adverum Biotechnologies, Inc.
174
9/29/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - CTMS - 40 active, 1 archive, 34 future active
Closed Won
Q3-2023
100
364
9/29/2022
10/1/2021
Renewal
0015000001nxYfoAAE
0015000001nxYfoAAE
eTMF
Vault
R&D
0015000001nxYfo
Calico Life Sciences LLC
175
9/29/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Seres Therapeutics, Inc.
Renewal 2022: Seres Therapeutics-Vault RIM, Clinical, & Quality
Closed Won
Q3-2023
100
363
9/29/2022
10/1/2021
Renewal
0015000000zPfrZAAS
0015000000zPfrZAAS
QualityDocs; Submissions; Submissions Archive
Vault
R&D
0015000000zPfrZ
Seres Therapeutics, Inc.
176
9/29/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Oct 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q3-2023
100
80
9/29/2022
7/11/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
177
9/30/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - Vault Quality Renewal
Closed Won
Q3-2023
100
365
9/30/2022
10/1/2021
Renewal
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000018Qz0A
Strongbridge Biopharma plc
178
9/30/2022
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore - Clinical
Closed Won
Q3-2023
100
262
9/30/2022
1/11/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
179
9/30/2022
EU Sales User - R&D SMB
Charlie Williams
MeiraGTx LLC
Renewal 2022: Meira GTX (New Logo) - eTMF 20 Sites
Closed Won
Q3-2023
100
360
9/30/2022
10/5/2021
Renewal
0012J00002XRL5vQAH
0012J00002XRL5vQAH
eTMF
Vault
R&D
0012J00002XRL5v
MeiraGTx LLC
180
10/7/2022
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
BD - CTMS & Payments Period 3 Renewal/Superseding final year, eTMF ELA Conversion
6. Awaiting P.O.
Q3-2023
99
847
10/7/2022
6/12/2020
Strategy Team
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
CTMS
Vault
R&D
0012J00002MKF7I
Becton, Dickinson and Company
181
10/12/2022
EU Sales User - R&D SMB
Davide Pesenti
EUSA Pharma (UK) Ltd
Recordati EUSA Migration 35 sites renewal 3 months
6. Awaiting P.O.
Q3-2023
99
46
10/12/2022
8/22/2022
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
00150000018O5PO
0015000000VSdDe
EUSA Pharma
182
10/14/2022
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
Surface Oncology Inc.
Renewal 2022: Surface Oncology: Vault Quality Docs & Training
6. Awaiting P.O.
Q3-2023
99
350
10/14/2022
10/22/2021
Sales
Subscription
00150000018PrBDAA0
00150000018PrBDAA0
R&D
00150000018PrBD
Surface Oncology, Inc
183
10/14/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Roivant Sciences, Inc.
Renewal 2022: Roivant Sciences - LearnGxP
4. Negotiation
Q3-2023
90
277
10/14/2022
1/3/2022
Sales
Subscription
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0015000001APsQw
Dermavant Sciences
184
10/14/2022
EU Sales User - R&D SMB
Charlie Williams
MeiraGTx LLC
Renewal 2022 Nov: MeiraGTx (New App) RIM - (Submissions, Archive 10 users)
5. Contracting
Q3-2023
99
37
10/14/2022
8/31/2022
Marketing
Subscription
0012J00002XRL5vQAH
0012J00002XRL5vQAH
R&D
0012J00002XRL5v
MeiraGTx LLC
185
10/15/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Ocugen, Inc.
Renewal 2022: Ocugen - QDocs & Training
4. Negotiation
Q3-2023
99
37
10/15/2022
8/31/2022
Sales Support
Subscription
0015000000tFn6fAAC
0015000000tFn6fAAC
R&D
0015000000tFn6f
Ocugen, Inc.
186
10/15/2022
EU Sales User - R&D SMB
Marco Macioszek
RICHTER-HELM BIOLOGICS GMBH & CO. KG
Renewal 2022: Richter-Helm - EU - QMS
6. Awaiting P.O.
Q3-2023
99
308
10/15/2022
12/3/2021
Sales
Subscription
0015000000ePgYjAAK
0015000000ePgYjAAK
R&D
0015000000ePgYj
RICHTER-HELM BIOLOGICS GMBH & CO. KG
187
10/17/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma - QD (EU+US) - Yr 3 renewal
Closed Won
Q3-2023
100
739
10/17/2022
10/8/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QualityDocs
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
188
10/20/2022
US Sales User - R&D SMB
Seth Fox
David Florez
Amneal Pharmaceuticals LLC
Renewal 2022: Amneal - QualityDocs
5. Contracting
Q3-2023
99
133
10/20/2022
5/27/2022
Sales
Subscription
0015000000LVRnaAAH
0012J00002MKhD2QAL
0012J00002MKhD2QAL
0012J00002MKhD2QAL
R&D
0015000000LVRna
0012J00002MKhD2
Impax Laboratories, Inc.
189
10/21/2022
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2022: Supernus Pharmaceuticals-QDocs, Training & QMS
4. Negotiation
Q3-2023
90
372
10/21/2022
10/1/2021
Renewal
0015000000PiLnMAAV
0015000000PiLnMAAV
QMS; QualityDocs
Vault
R&D
0015000000PiLnM
Supernus Pharmaceuticals, Inc.
190
10/21/2022
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
Shattuck Labs, Inc.
Renewal 2022: Shattuck Labs - 100 ELAVault Submissions and 8 Submissions Archive
4. Negotiation
Q3-2023
95
351
10/21/2022
10/21/2021
Other
Subscription
0012J00002QJUllQAH
0012J00002QJUllQAH
R&D
0012J00002QJUll
Shattuck Labs, Inc.
191
10/21/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH - SiteConnect
5. Contracting
Q3-2023
99
236
10/21/2022
2/13/2022
Sales
Subscription
00150000014RszdAAC
00150000014RszdAAC
R&D
00150000014Rszd
St. Jude Children's Research Hospital
192
10/21/2022
EU Sales User - R&D ENT
Zoltan Szarka
GSK
Renewal 2022: GSK Vault Platform Health Outcome Tracker
3. Proposal
Q3-2023
90
343
10/21/2022
10/29/2021
Sales
Subscription
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0012J00002LPpFr
Tesaro, Inc.
193
10/21/2022
EU Sales User - R&D SMB
Katrine Bødker Christensen
Oncopeptides AB
Renewal 2022: Oncopeptides- QD, RIM
4. Negotiation
Q3-2023
99
246
10/21/2022
2/3/2022
Sales
Subscription
0015000001RQkXdAAL
0015000001RQkXdAAL
R&D
0015000001RQkXd
Oncopeptides AB
194
10/25/2022
LatAm Sales User
Luis Fernandez
Laboratorios Sophia, S.A. de C.V.
Renewal 2022: Sophia Mexico eTMF total: 25 Active sites + 1 Archive site
2. Discovery
Q3-2023
30
347
10/25/2022
10/25/2021
Sales
Subscription
0012J00002LPqbwQAD
0012J00002LPqbwQAD
R&D
0012J00002LPqbw
Laboratorios Sophia
195
10/27/2022
CN Sales User - R&D ENT
Stephanie Zhang
Suzhou Ceclor Pharmaceutical Co., Ltd.
Renewal 2022: Ceclor-China-QMS-biotech ELA250
5. Contracting
Q3-2023
99
345
10/27/2022
10/27/2021
Strategy Team
Subscription
0012J00002U7d2UQAR
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002U7d2U
0015000000tsIxG
Ceclor
196
10/31/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon Submissions, Submissions Archive and Publishing
4. Negotiation
Q3-2023
95
319
10/31/2022
11/22/2021
Sales
Subscription
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
197
10/31/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Intarcia Therapeutics, Inc.
Renewal 2022: Intarcia Therapeutics_Veeva QualityDocs Superseding Licensing Extension October 2022
4. Negotiation
Q3-2023
95
178
10/31/2022
4/12/2022
Subscription
0015000001IfBXpAAN
0015000001IfBXpAAN
R&D
0015000001IfBXp
Intarcia Therapeutics, Inc.
198
10/31/2022
JP Sales User - R&D ENT
Junichiro Tomoda
ASAHI KASEI PHARMA CORPORATION
Renewal 2022: Asahikasei Pharma eTMF 32sites - Japan Local Deal
4. Negotiation
Q3-2023
90
302
10/31/2022
12/9/2021
Sales
Subscription
0015000000ORqreAAD
0015000000ORqreAAD
R&D
0015000000ORqre
Asahi Kasei Pharma
199
10/31/2022
EU Sales User - CDMS
Sam Rolfe
Exom Group Srl
Renewal Dec 2022: Exom - eTMF - 162 sites - dec -feb 3 months
4. Negotiation
Q3-2023
95
77
10/31/2022
7/22/2022
Sales
Subscription
0015000000tptQnAAI
0015000000tptQnAAI
R&D
0015000000tptQn
Exom Group
200
11/1/2022
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
Sanaria
Renewal 2022: Sanaria_Veeva Vault eTMF Renewal
2. Discovery
Q4-2023
0
358
11/1/2022
10/14/2021
Renewal
0015000000mNPPqAAO
0015000000mNPPqAAO
eTMF
Vault
R&D
0015000000mNPPq
Sanaria, Inc.
201
11/1/2022
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
Dova Pharmaceuticals, Inc.
Renewal 2022: Dova RIM short term
4. Negotiation
Q4-2023
95
340
11/1/2022
11/1/2021
Sales
Subscription
0015000001Niyx9AAB
0015000000OU1qNAAT
0015000000OU1qNAAT
0015000000OU1qNAAT
R&D
0015000001Niyx9
0015000000OU1qN
Dova Pharmaceuticals, LLC
202
11/1/2022
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2023: Jazz Pharmaceuticals - New Vault - RIM
5. Contracting
Q4-2023
98
267
11/1/2022
1/13/2022
Sales
Subscription
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
203
11/3/2022
CN Sales User - R&D SMB
Shirley Wang
Mabspace Biosciences (Suzhou) Co. LTd.
Renewal 2022: Mabspacebio-China-QualityDocs-China Biotech ELA 250
4. Negotiation
Q4-2023
95
338
11/3/2022
11/3/2021
Sales
Subscription
0012J00002Qdd40QAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002Qdd40
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
204
11/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal Dec 2022: Atlantic Research Group - CTMS
4. Negotiation
Q4-2023
95
46
11/4/2022
8/22/2022
Sales
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
205
11/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal Dec 2022: Atlantic Research Group eTMF Full Account Renewal 12/1/2022
4. Negotiation
Q4-2023
95
46
11/4/2022
8/22/2022
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
206
11/5/2022
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
HilleVax, Inc.
Renewal Dec 2022: HilleVax Submissions and Subs A
5. Contracting
Q4-2023
99
127
11/5/2022
6/2/2022
Sales
Subscription
0012J00002U6WwuQAF
0012J00002U6WwuQAF
R&D
0012J00002U6Wwu
HilleVax
207
11/10/2022
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal 2022 Dizal-China-eTMF-China Biotech ELA 250
Closed Won
Q4-2023
100
716
11/10/2022
11/24/2020
Renewal
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
eTMF
Vault
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
208
11/11/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Dec 2022: S3 DMID-BET - Consolidated 61 Sites
4. Negotiation
Q4-2023
95
8
11/11/2022
9/29/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
209
11/15/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI Vault Subs/Subs A - CCR Vault
4. Negotiation
Q4-2023
99
400
11/15/2022
9/2/2021
Renewal
0015000000olZKlAAM
0015000000olZKlAAM
Submissions; Submissions Archive
Vault
R&D
0015000000olZKl
Technical Resources International, Inc.
210
11/15/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Renewal 2022: Turning Point Therapeutics - Submissions and Submissions Archive
4. Negotiation
Q4-2023
80
175
11/15/2022
4/15/2022
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
211
11/15/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal Dec 2022: TRI eTMF 12-1-2022
4. Negotiation
Q4-2023
95
128
11/15/2022
6/1/2022
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
212
11/16/2022
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Spero Therapeutics, Inc.
Renewal 2022: Spero Therapeutics- QD, VT and QMS ELA 100
5. Contracting
Q4-2023
99
322
11/16/2022
11/19/2021
Sales
Subscription
0015000001ODHG9AAP
0015000001ODHG9AAP
R&D
0015000001ODHG9
Spero Therapeutics, Inc.
213
11/16/2022
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Spero Therapeutics, Inc.
Renewal 2022: Spero Therapeutics- RIM ELA
5. Contracting
Q4-2023
99
310
11/16/2022
12/1/2021
Sales
Subscription
0015000001ODHG9AAP
0015000001ODHG9AAP
R&D
0015000001ODHG9
Spero Therapeutics, Inc.
214
11/17/2022
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
La Jolla Pharmaceutical Company
Renewal 2022: La Jolla Pharmaceutical Company ? Submissions-eTMF-QualityDocs
4. Negotiation
Q4-2023
95
324
11/17/2022
11/17/2021
Sales
Subscription
0015000000Lq8CdAAJ
0015000000Lq8CdAAJ
R&D
0015000000Lq8Cd
La Jolla Pharmaceutical Company
215
11/18/2022
EU Sales User - MedTech ENT
Eleni Tragousti
Institut Straumann AG
Renewal 2022: Straumann - Vault QMS - period 1 - 8
Closed Won
Q4-2023
100
403
11/18/2022
10/11/2021
Sales
Subscription
0012J00002U5C7vQAF
0012J00002U5C7vQAF
QMS
Vault
R&D
0012J00002U5C7v
Straumann Usa, LLC
216
11/23/2022
EU Sales User - R&D SMB
Hasse Rando
Swedish Orphan Biovitrum AB (publ)
Renewal 2023: SOBI RIM
4. Negotiation
Q4-2023
95
318
11/23/2022
11/23/2021
Sales
Subscription
0015000000OU1qNAAT
0015000000OU1qNAAT
R&D
0015000000OU1qN
Dova Pharmaceuticals, LLC
217
11/24/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2022: Arcturus Therapeutics - Vault eTMF - 19 eTMF Active Sites & 2 Archive Sites
3. Proposal
Q4-2023
70
317
11/24/2022
11/24/2021
Sales
Subscription
0015000000r8H7sAAE
0015000000r8H7sAAE
R&D
0015000000r8H7s
Arcturus Therapeutics, Inc.
218
11/30/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Acorda Therapeutics, Inc.
Renewal 2022: Acorda Therapeutics - Quality & eTMF
4. Negotiation
Q4-2023
99
64
11/30/2022
8/4/2022
Subscription
0015000000IO26iAAD
0015000000IO26iAAD
R&D
0015000000IO26i
Acorda Therapeutics, Inc.
219
11/30/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2023 Jan: GSK Pharma Vault QMS P3
6. Awaiting P.O.
Q4-2023
99
687
11/30/2022
11/19/2020
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
QMS
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
220
11/30/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal: GSK Consumer Safety 2023
6. Awaiting P.O.
Q4-2023
99
666
11/30/2022
12/10/2020
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Vault Safety
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
221
11/30/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati Rare Diseases, Inc.
Renewal Dec 2022: Recordati US- Vault Training - 153 users
4. Negotiation
Q4-2023
95
70
11/30/2022
7/29/2022
Subscription
0015000000pJSINAA4
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0015000000pJSIN
0015000000VSdDe
Recordati Rare Diseases, Inc.
222
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2023: Vaxart - Vault Sub/SubA - 50 ELA + 5 Archive Users
4. Negotiation
Q4-2023
90
399
12/1/2022
9/3/2021
Renewal
0015000001HesyBAAR
0015000001HesyBAAR
Submissions; Submissions Archive
Vault
R&D
0015000001HesyB
Vaxart Inc
223
12/1/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
ADC Therapeutics SA
Renewal 2022: ADC Therapeutics - (New Logo) - Submissions Archive
4. Negotiation
Q4-2023
95
352
12/1/2022
10/20/2021
Sales
Subscription
0015000001CrmGfAAJ
0015000001HhQaiAAF
0015000001HhQaiAAF
0015000001HhQaiAAF
R&D
0015000001CrmGf
0015000001HhQai
ADC Therapeutics
224
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2023 Jan: Vaxart - Vault QualityDocs/Training - 200 ELA
4. Negotiation
Q4-2023
90
340
12/1/2022
11/1/2021
Sales
Subscription
0015000001HesyBAAR
0015000001HesyBAAR
R&D
0015000001HesyB
Vaxart Inc
225
12/1/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Iterum Therapeutics International Limited
Renewal 2023: Iterum Therapeutics_Vault eTMF and RIM
4. Negotiation
Q4-2023
95
326
12/1/2022
11/15/2021
Subscription
00150000014TbQlAAK
00150000014TbQlAAK
R&D
00150000014TbQl
Iterum Therapeutics International Limited
226
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2022: Vaxart Inc - eTMF - 6 Active Sites, 10 Archive Sites, 26 add-on active sites
4. Negotiation
Q4-2023
90
296
12/1/2022
12/15/2021
Subscription
0015000001HesyBAAR
0015000001HesyBAAR
R&D
0015000001HesyB
Vaxart Inc
227
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Rigel Pharmaceuticals, Inc.
Renewal 2022: Rigel - QD:37 Full Users, 55 RO Users - VT: 4 Admin Users, 88 Learner Users
4. Negotiation
Q4-2023
90
291
12/1/2022
12/20/2021
Subscription
0015000000NCeXCAA1
0015000000NCeXCAA1
R&D
0015000000NCeXC
Rigel Pharmaceuticals, Inc.
228
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Rigel Pharmaceuticals, Inc.
Renewal 2022: Rigel - eTMF - 223 Active Sites
4. Negotiation
Q4-2023
90
291
12/1/2022
12/20/2021
Sales
Subscription
0015000000NCeXCAA1
0015000000NCeXCAA1
R&D
0015000000NCeXC
Rigel Pharmaceuticals, Inc.
229
12/1/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Neurogene
Renewal 2023: Neurogene_Vault Quality Suite (QualityDocs, Training, QMS)
4. Negotiation
Q4-2023
95
221
12/1/2022
2/28/2022
Subscription
0012J00002IlRrWQAV
0012J00002IlRrWQAV
R&D
0012J00002IlRrW
Neurogene
230
12/1/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Idera Pharmaceuticals, Inc.
Renewal 2022: Idera - Submissions
4. Negotiation
Q4-2023
95
219
12/1/2022
3/2/2022
Sales
Subscription
0015000000MoUgQAAV
0015000000MoUgQAAV
R&D
0015000000MoUgQ
Idera Pharmaceuticals, Inc.
231
12/1/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Cullinan Oncology
Renewal 2023: Cullinan Oncology - Quality Docs/Training
4. Negotiation
Q4-2023
95
203
12/1/2022
3/18/2022
Subscription
0012J00002N4H28QAF
0012J00002N4H28QAF
R&D
0012J00002N4H28
Cullinan Oncology
232
12/1/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Cullinan Oncology
Renewal 2023: Cullinan Oncology - eTMF - (32)
3. Proposal
Q4-2023
40
163
12/1/2022
4/27/2022
Subscription
0012J00002N4H28QAF
0012J00002N4H28QAF
R&D
0012J00002N4H28
Cullinan Oncology
233
12/1/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Sention Therapeutics, LLC
Renewal 2023: Sention Therapeutics - RIM, Quality, & Clinical
5. Contracting
Q4-2023
95
161
12/1/2022
4/29/2022
Sales
Subscription
0012J00002XV4NEQA1
0012J00002XV4NEQA1
R&D
0012J00002XV4NE
Sention Therapeutics
234
12/1/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Intercept Pharmaceuticals, Inc.
Renewal 2023: Intercept - Vault eTMF - 25 Active Sites
5. Contracting
Q4-2023
95
151
12/1/2022
5/9/2022
Sales
Subscription
0015000000iRqSVAA0
0015000000iRqSVAA0
R&D
0015000000iRqSV
Intercept Pharmaceuticals, Inc.
235
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2023: GSK | SSU 2022
5. Contracting
Q4-2023
99
1099
12/1/2022
10/4/2019
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Study Startup
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
236
12/1/2022
EU Sales User - R&D SMB
Reto Flury
Ferring Pharmaceuticals A/S
Renewal 2023: Ferring - Vault CTMS/SSU/Payments
5. Contracting
Q4-2023
98
331
12/1/2022
11/10/2021
Subscription
0012J00002N5k6lQAB
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0012J00002N5k6l
0012J00002MKF7X
FerGene
237
12/1/2022
US Sales User - Safety
Michael Heimann
SCTbio a.s.
Renewal 2022: SOTIO A.S. - QDocs ELA 100 + QMS ELA 100
4. Negotiation
Q4-2023
95
310
12/1/2022
12/1/2021
Other
Subscription
0015000000ePOfRAAW
0015000000ePOfRAAW
R&D
0015000000ePOfR
SCTbio a.s.
238
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
F. HOFFMANN-LA ROCHE AG
Renewal 2023: Roche Diagnostics SRT - 235 Licenses
5. Contracting
Q4-2023
99
303
12/1/2022
12/8/2021
Subscription
0015000000aQSXBAA4
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000aQSXB
0012J00002MJstk
Chugai Pharmaceutical Co.,Ltd.
239
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma eTMF ELA
6. Awaiting P.O.
Q4-2023
99
295
12/1/2022
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
240
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma CTMS ELA
6. Awaiting P.O.
Q4-2023
99
295
12/1/2022
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
241
12/1/2022
EU Sales User - R&D ENT
Maxime Orain
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson QualityDocs EU
4. Negotiation
Q4-2023
95
288
12/1/2022
12/23/2021
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
242
12/1/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati Rare Diseases Sarl
Renewal 2022 Dec: Renewal-Recordati Rare Diseases FR- eTMF 2021
4. Negotiation
Q4-2023
99
248
12/1/2022
2/1/2022
Sales
Subscription
0012J00002ZZKmtQAH
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0012J00002ZZKmt
0015000000VSdDe
EUSA Pharma
243
12/1/2022
US Sales User - Safety
Michael Heimann
SOTIO Biotech a.s.
Renewal 2022: SOTIO Biotech - QDocs ELA 200 / QMS ELA 200
4. Negotiation
Q4-2023
95
219
12/1/2022
3/2/2022
Sales
Subscription
0012J00002X2YJBQA3
0015000000ePOfRAAW
0015000000ePOfRAAW
0015000000ePOfRAAW
R&D
0012J00002X2YJB
0015000000ePOfR
SCTbio a.s.
244
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline Biologicals SA
Renewal 2023: GSK Vaccines Vault Platform Reg Intel QRI 2021
5. Contracting
Q4-2023
99
203
12/1/2022
3/18/2022
Subscription
0015000000iVjitAAC
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000iVjit
0012J00002MJmoR
Tesaro, Inc.
245
12/1/2022
EU Sales User - R&D ENT
Julien Bechtel
UCB Biopharma SRL
Renewal Jan 2023: UCB Zogenix Legacy eTMF - $0 OF For migration
4. Negotiation
Q4-2023
95
35
12/1/2022
9/2/2022
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
246
12/1/2022
US Sales User - R&D ENT
Lori Thorell
MSD Pharmaceuticals
Renewal 2023: Merck_Vault eTMF_
5. Contracting
Q4-2023
99
297
12/1/2022
12/14/2021
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
247
12/1/2022
US Sales User - R&D SMB
Anthony Gotzis
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson QualityDocs - US split
4. Negotiation
Q4-2023
95
265
12/1/2022
1/15/2022
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
248
12/1/2022
US Sales User - Commercial ENT
Stefan Jahnecke
Elanco US Inc.
Renewal 2023: Elanco - CTMS + eTMF ELA
4. Negotiation
Q4-2023
95
310
12/1/2022
12/1/2021
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
R&D
0015000000KQOA1
0012J00002MKyhe
Elanco Animal Health Inc.
249
12/1/2022
US Sales User - MedTech ENT
David Duffy
Boston Scientific Corporation
Renewal 2022: Boston Scientific - QMS
5. Contracting
Q4-2023
99
318
12/1/2022
11/23/2021
Sales
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
R&D
0015000000LVRzo
0012J00002MKhDC
Boston Scientific
250
12/2/2022
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2022: Abbott Diabetes Care - NA - eTMF - 230ELA
5. Contracting
Q4-2023
99
309
12/2/2022
12/2/2021
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
251
12/2/2022
US Sales User - R&D ENT
Chris McShea
MSD Pharmaceuticals
Renewal 2022: Merck - QMS MRL
6. Awaiting P.O.
Q4-2023
99
309
12/2/2022
12/2/2021
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
252
12/3/2022
EU Sales User - R&D ENT
Zoltan Szarka
Roche Diagnostics GmbH
Renewal 2022: Roche DIA - Veeva eConsent
2. Discovery
Q4-2023
20
308
12/3/2022
12/3/2021
Sales
Subscription
0015000000pJthCAAS
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000pJthC
0012J00002MJsuJ
Chugai Pharmaceutical Co.,Ltd.
253
12/7/2022
EU Sales User - R&D ENT
Mathieu De Sazilly
UCB Biopharma SRL
Renewal 2022: UCB - NextGen ECMS - SubmissionsArchive 20 users
4. Negotiation
Q4-2023
95
304
12/7/2022
12/7/2021
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
254
12/7/2022
US Sales User - R&D ENT
Chris McShea
MSD Pharmaceuticals
Renewal 2022: Merck_RA HH_RIM Suite_Year 6 Renewal
5. Contracting
Q4-2023
99
304
12/7/2022
12/7/2021
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
255
12/9/2022
EU Sales User - CDMS
Georg Schumm
Health Data Specialists S.A.
Renewal 2023: HeadsCRO - eTMF - 32 sites
4. Negotiation
Q4-2023
95
302
12/9/2022
12/9/2021
Sales
Subscription
0015000002IigC0AAJ
0015000002IigC0AAJ
R&D
0015000002IigC0
Health Data Specialists S.A.
256
12/10/2022
EU Sales User - R&D ENT
Zoltan Szarka
Roche Diagnostics GmbH
Renewal 2023: Roche Diagnostics eTMF ELA
5. Contracting
Q4-2023
99
330
12/10/2022
11/11/2021
Subscription
0015000000pJthCAAS
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000pJthC
0012J00002MJsuJ
Chugai Pharmaceutical Co.,Ltd.
257
12/10/2022
EU Sales User - R&D ENT
Zoltan Szarka
Roche Diabetes Care GmbH
Renewal 2023: Roche Diabetes Care CTMS, SSU, Payments
3. Proposal
Q4-2023
90
270
12/10/2022
1/10/2022
Subscription
00150000019uxEyAAI
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
00150000019uxEy
0012J00002MJstk
Chugai Pharmaceutical Co.,Ltd.
258
12/13/2022
EU Sales User - R&D ENT
Jürgen Grampp
F. Hoffmann-La Roche Ltd
Renewal 2023: Roche HTAg 1000 RO and 150 FU (EU&US)
6. Awaiting P.O.
Q4-2023
99
298
12/13/2022
12/13/2021
Subscription
0015000000VSdHgAAL
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000VSdHg
0012J00002MJstk
Chugai Pharmaceutical Co.,Ltd.
259
12/14/2022
US Sales User - MedTech ENT
Brendan Boere
Cerus Corporation
Renewal 2023: Cerus Corporation - QMS ELA400
4. Negotiation
Q4-2023
95
297
12/14/2022
12/14/2021
Sales
Subscription
0015000000Lq8BBAAZ
0015000000Lq8BBAAZ
R&D
0015000000Lq8BB
Cerus Corporation
260
12/14/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma RIM ELA
4. Negotiation
Q4-2023
95
297
12/14/2022
12/14/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
261
12/14/2022
EU Sales User - R&D SMB
Davide Pesenti
EUSA Pharma (UK) Ltd
Renewal 2022: EUSA Pharma (UK) Ltd - Vault QMS and QualityDocs - ELA 400
4. Negotiation
Q4-2023
95
297
12/14/2022
12/14/2021
Sales
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
00150000018O5PO
0015000000VSdDe
EUSA Pharma
262
12/14/2022
US Sales User - R&D SMB
Teri Smith
Ernie Chin
American Regent, Inc.
Renewal 2023: American Regent _QDocs ELA
6. Awaiting P.O.
Q4-2023
99
297
12/14/2022
12/14/2021
Sales
Subscription
0015000000IO26vAAD
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
R&D
0015000000IO26v
0012J00002bzOnv
Daiichi Sankyo Co.,LTD
263
12/15/2022
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Endpoint Health Inc.
Renewal 2023: Endpoint Health - Vault eTMF/CTMS - 25 Site Count
3. Proposal
Q4-2023
95
296
12/15/2022
12/15/2021
Sales
Subscription
0012J00002ZExxBQAT
0012J00002ZExxBQAT
R&D
0012J00002ZExxB
Endpoint Health
264
12/15/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Luye Pharma (USA), Ltd
Renewal 2023: Luye - Vault Publishing
2. Discovery
Q4-2023
30
262
12/15/2022
1/18/2022
Subscription
0015000001MbT4CAAV
00150000025cbFjAAI
00150000025cbFjAAI
00150000025cbFjAAI
R&D
0015000001MbT4C
00150000025cbFj
Shandong Luye Pharmaceutical Co., Ltd
265
12/15/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Luye Pharma (USA), Ltd
Renewal 2023: Luye Pharma - US - Submissions
4. Negotiation
Q4-2023
95
262
12/15/2022
1/18/2022
Subscription
0015000001MbT4CAAV
00150000025cbFjAAI
00150000025cbFjAAI
00150000025cbFjAAI
R&D
0015000001MbT4C
00150000025cbFj
Shandong Luye Pharmaceutical Co., Ltd
266
12/15/2022
US Sales User - R&D SMB
Anthony Gotzis
J&J Pharmaceuticals
Renewal Jan 2023: Momenta RIM, QD, QMS, Training ELA200
4. Negotiation
Q4-2023
99
79
12/15/2022
7/20/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
267
12/16/2022
US Sales User - R&D SMB
Tai Hornbeck
Jim Thai
Neurelis, Inc.
Renewal 2022: Neurelis - Vault QualityDocs and Vault Training - 200 ELA
4. Negotiation
Q4-2023
95
295
12/16/2022
12/16/2021
Subscription
0015000002IjF01AAF
0015000002IjF01AAF
R&D
0015000002IjF01
Neurelis, Inc.
268
12/16/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati S.P.A.
Renewal 2022: Recordati - Vault Development Cloud December
4. Negotiation
Q4-2023
95
254
12/16/2022
1/26/2022
Sales
Subscription
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0015000000VSdDe
EUSA Pharma
269
12/16/2022
LatAm Manager - Sales
Antonio Faggioni
Cellera Famacêutica S/A
Renewal 2022: Cellera Brazil Submissions 8 Users + Base
4. Negotiation
Q4-2023
95
295
12/16/2022
12/16/2021
Sales
Subscription
0012J00002J2vsZQAR
0012J00002J2vsZQAR
R&D
0012J00002J2vsZ
Cellera Farma
270
12/17/2022
US Sales User - R&D SMB
Alexandra Furdyna
International AIDS Vaccine Initiative, Inc.
Renewal 2023: IAVI- eTMF 4 Archive Sites Mult-Year T002 Trial
Closed Won
Q4-2023
100
712
12/17/2022
1/4/2021
Renewal
00150000019DKfQAAW
00150000019DKfQAAW
eTMF
Vault
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
271
12/17/2022
EU Sales User - R&D ENT
Katrien Mesotten
Sanofi Aventis Groupe
RENEWAL: 2023 Sanofi - eTMF ELA Yr 4 - US&EU
5. Contracting
Q4-2023
90
1247
12/17/2022
5/9/2019
Renewal
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
eTMF
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
272
12/17/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
GSK Pharma Payments P3 Renewal
Closed Won
Q4-2023
100
871
12/17/2022
7/29/2020
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Payments
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
273
12/17/2022
EU Sales User - R&D ENT
Katrien Mesotten
UCB Biopharma SRL
Renewal 2023: UCB - Trackwise replacement - QMS & QD ELA Y3
Closed Won
Q4-2023
100
754
12/17/2022
11/23/2020
Sales
Renewal
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
QMS; QualityDocs
Vault
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
274
12/17/2022
EU Sales User - R&D ENT
Katrien Mesotten
J&J Pharmaceuticals
Renewal 2023: Janssen - Vault Platform - Grants Management - 60 FU 70 RO - Global
4. Negotiation
Q4-2023
90
249
12/17/2022
1/31/2022
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
275
12/17/2022
US Sales User - R&D ENT
Samantha Sykora
Roche Diagnostics Operations, Inc
Renewal 2023: Roche Diagnostics - Vault QMS Audit - EU&US
5. Contracting
Q4-2023
99
316
12/17/2022
11/25/2021
Sales
Subscription
0015000000LXz5MAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000LXz5M
0012J00002MJsuJ
Chugai Pharmaceutical Co.,Ltd.
276
12/17/2022
US Sales User - R&D ENT
Samantha Sykora
Roche Diagnostics Operations, Inc
Renewal 2023: Roche Diagnostics - RIM - EU/US Renewal
4. Negotiation
Q4-2023
99
309
12/17/2022
12/2/2021
Sales
Subscription
0015000000LXz5MAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000LXz5M
0012J00002MJsuJ
Chugai Pharmaceutical Co.,Ltd.
277
12/18/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Intercept Pharmaceuticals, Inc.
Renewal 2023: Intercept - Vault Submissions ELA, SubsA 10 users, Registrations 20 users
5. Contracting
Q4-2023
95
293
12/18/2022
12/18/2021
Sales
Subscription
0015000000iRqSVAA0
0015000000iRqSVAA0
R&D
0015000000iRqSV
Intercept Pharmaceuticals, Inc.
278
12/18/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
TG Therapeutics, Inc.
Renewal 2023: TG Therapeutics - Submissions Archive - 19 Users
1. Prospecting
Q4-2023
10
293
12/18/2022
12/18/2021
Sales
Subscription
0015000000dbgxqAAA
0015000000dbgxqAAA
R&D
0015000000dbgxq
TG Therapeutics, Inc.
279
12/18/2022
EU Sales User - R&D ENT
Katrien Mesotten
UCB Biopharma SRL
Renewal 2023 UCB Submission,eTMF,Registrations ELA superseding Y3
Closed Won
Q4-2023
100
755
12/18/2022
11/23/2020
Sales
Renewal
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
eTMF; Registrations; Submissions
Vault
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
280
12/21/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Kadmon Pharmaceuticals, LLC
Renewal 2023: Kadmon Multi-Vault
4. Negotiation
Q4-2023
95
290
12/21/2022
12/21/2021
Subscription
0015000000YHQeAAAX
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
R&D
0015000000YHQeA
0015000001TVjdf
Kadmon Corporation, LLC
281
12/21/2022
US Sales User - R&D ENT
Chris McShea
Acceleron Pharma Inc.
Renewal 2022: Acceleron- Submissions
4. Negotiation
Q4-2023
80
290
12/21/2022
12/21/2021
Sales
Subscription
0015000000Lq8AVAAZ
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0015000000Lq8AV
0012J00002LPcIz
Acceleron Pharma Inc.
282
12/21/2022
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
Renewal 2023: Sanofi - Vault RIM (Reg,Sub,SubA) ELA Renewal
5. Contracting
Q4-2023
99
290
12/21/2022
12/21/2021
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
283
12/22/2022
US Sales User - MedTech ENT
Brendan Boere
Cerus Corporation
Renewal 2022: Cerus Corporation - eTMF Active Sites
4. Negotiation
Q4-2023
99
289
12/22/2022
12/22/2021
Subscription
0015000000Lq8BBAAZ
0015000000Lq8BBAAZ
R&D
0015000000Lq8BB
Cerus Corporation
284
12/22/2022
US Sales User - R&D ENT
Greg Boudreau
Takeda Pharmaceuticals U.S.A., Inc.
Renewal: Takeda- QualityDocs - Global - Year 3
Closed Won
Q4-2023
100
854
12/22/2022
8/20/2020
Sales
Subscription
0015000000IO28HAAT
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
QualityDocs
Vault
R&D
0015000000IO28H
0012J00002MJsv2
Shire Pharmaceuticals Inc.
285
12/26/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Jan 2023: Haleon (GSK CH) 300025 - SH 7035155
4. Negotiation
Q4-2023
95
11
12/26/2022
9/26/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
286
12/30/2022
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2023: Supernus - LearnGxP - annual training material
4. Negotiation
Q4-2023
95
247
12/30/2022
2/2/2022
Sales
Subscription
0015000000PiLnMAAV
0015000000PiLnMAAV
R&D
0015000000PiLnM
Supernus Pharmaceuticals, Inc.
287
12/31/2022
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
2023 Renewal: Nektar Therapeutics - QMS ELA
5. Contracting
Q4-2023
95
45
12/31/2022
8/23/2022
Sales
Subscription
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
288
12/31/2022
EU Manager - R&D Sales
Alejandro Pina
Zambon S.p.A.
Renewal 2023: Zambon - Vault RIM & eTMF
5. Contracting
Q4-2023
99
290
12/31/2022
12/21/2021
Sales
Subscription
0015000000OgSzlAAF
0015000000OgSzlAAF
R&D
0015000000OgSzl
ZAMBON GROUP SPA
289
1/1/2023
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
TherapeuticsMD, Inc.
Renewal 2023: TherapeuticsMD New SubmissionsArchive
2. Discovery
Q4-2023
80
373
1/1/2023
9/29/2021
Renewal
0015000000dbU1sAAE
0015000000dbU1sAAE
Submissions Archive
Vault
R&D
0015000000dbU1s
TherapeuticsMD, Inc
290
1/1/2023
US Sales User - MedTech ENT
Dorian Wolff
Insulet Corporation
Renewal 2023: Insulet- RIM
5. Contracting
Q4-2023
98
322
1/1/2023
11/19/2021
Sales
Subscription
0015000000OfTIYAA3
0015000000OfTIYAA3
R&D
0015000000OfTIY
Insulet Corporation
291
1/1/2023
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Assembly Biosciences, Inc.
Renewal 2023: Assembly Biosciences - Vault Subs/SubsA, QDocs, Training, & eTMF/eTMF Archive
4. Negotiation
Q4-2023
95
259
1/1/2023
1/21/2022
Subscription
0015000001MbWOaAAN
0015000001MbWOaAAN
R&D
0015000001MbWOa
Assembly Biosciences
292
1/1/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Neurogene
Renewal 2023: Neurogene_Vault RIM (Submissions/Submissions Archive)
4. Negotiation
Q4-2023
95
256
1/1/2023
1/24/2022
Sales
Subscription
0012J00002IlRrWQAV
0012J00002IlRrWQAV
R&D
0012J00002IlRrW
Neurogene
293
1/1/2023
US Sales User - CRO
Joey Sineno
Katie Tipton
Paragon Bioteck, Inc.
Renewal 2023: Paragon Bioteck, Vault Submissions and SubmissionsArchive
4. Negotiation
Q4-2023
90
137
1/1/2023
5/23/2022
Subscription
0015000001KNAOJAA5
0015000001Dqpq2AAB
0015000001Dqpq2AAB
0015000001Dqpq2AAB
R&D
0015000001KNAOJ
0015000001Dqpq2
Paragon Bioteck, Inc.
294
1/1/2023
US Sales User - MedTech ENT
Dorian Wolff
Roche MedTech
Renewal 2023: FMI QMS ELA & QDocs ELA
5. Contracting
Q4-2023
99
31
1/1/2023
9/6/2022
Sales
Subscription
0012J00002ZERRvQAP
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0012J00002ZERRv
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
295
1/1/2023
US Sales User - MedTech ENT
Dorian Wolff
Roche MedTech
Renewal 2023: FMI - Companion Study Model CTMS / eTMF
5. Contracting
Q4-2023
99
30
1/1/2023
9/7/2022
Sales
Subscription
0012J00002ZERRvQAP
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0012J00002ZERRv
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
296
1/1/2023
Asia Pac Sales User - R&D ENT
Amber Lee
MEDYTOX
Renewal 2023: Medytox eTMF 32 Active sites renewal
2. Discovery
Q4-2023
80
240
1/1/2023
2/9/2022
Subscription
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0015000001KNJti
MEDYTOX
297
1/1/2023
US Sales User - MedTech ENT
David Duffy
Boston Scientific Corporation
Boston Scientific eTMF/CTMS- Year 3 Renewal of ELA
6. Awaiting P.O.
Q4-2023
99
1285
1/1/2023
4/1/2019
Sales
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
eTMF
Vault
R&D
0015000000LVRzo
0012J00002MKhDC
Boston Scientific
298
1/4/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Urovant Sciences, Inc.
Renewal 2023: Urovant (SV) - Vault QualityDocs & Training ELA200
4. Negotiation
Q4-2023
95
276
1/4/2023
1/4/2022
Sales
Subscription
0015000001RO2Q4AAL
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000001RO2Q4
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
299
1/5/2023
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
Kiniksa Pharmaceuticals Corp.
Renewal 2023: Kiniksa Pharmaceuticals- QualityDocs, Training and QMS
4. Negotiation
Q4-2023
95
275
1/5/2023
1/5/2022
Subscription
0015000001HfFYcAAN
0015000001HfFYcAAN
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
300
1/6/2023
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2023: Immunocore_Vault CTMS
4. Negotiation
Q4-2023
95
274
1/6/2023
1/6/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
301
1/6/2023
EU Sales User - R&D SMB
Charlie Williams
Cycle Pharmaceuticals Ltd.
Renewal 2023: Cycle Pharmaceuticals Ltd. - Vault Submissions & Submissions Archive
4. Negotiation
Q4-2023
95
274
1/6/2023
1/6/2022
Sales
Subscription
00150000019CzsZAAS
00150000019CzsZAAS
R&D
00150000019CzsZ
CYCLE PHARMACEUTICALS LTD
302
1/6/2023
EU Sales User - R&D SMB
Charlie Williams
Trizell Ltd
Renewal 2023: Trizell - Submissions 20 users
4. Negotiation
Q4-2023
95
274
1/6/2023
1/6/2022
Subscription
0015000001MaFTKAA3
0015000001MaFTKAA3
R&D
0015000001MaFTK
FKD Therapies
303
1/6/2023
US Sales User - R&D ENT
Chris McShea
MSD Pharmaceuticals
Renewal 2023: Merck_Vault QualityDocs - ELA Conversion Steady State Renewal 2022
6. Awaiting P.O.
Q4-2023
99
274
1/6/2023
1/6/2022
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
304
1/8/2023
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Feb 2023: Haleon (GSK CH) 300024 / SH 7035173
4. Negotiation
Q4-2023
95
46
1/8/2023
8/22/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
305
1/11/2023
US Sales User - R&D SMB
Julie Bolger
Ernie Chin
Amarin Corporation
Renewal 2023: Amarin QDOCS
5. Contracting
Q4-2023
98
269
1/11/2023
1/11/2022
Sales
Subscription
0015000000MMajDAAT
0015000000MMajDAAT
R&D
0015000000MMajD
Amarin Corporation (US Headquarters)
306
1/12/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
BioXcel Therapeutics, Inc.
Renewal 2023: BioXcel - QualityDocs/Training ELA200 & RIM
4. Negotiation
Q4-2023
95
291
1/12/2023
12/20/2021
Subscription
0015000002Ijr2RAAR
0015000002Ijr2RAAR
R&D
0015000002Ijr2R
BioXcel Therapeutics
307
1/12/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal 2023: Myovant Sciences - Vault QualityDocs & Training
4. Negotiation
Q4-2023
95
268
1/12/2023
1/12/2022
Sales
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
308
1/12/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
BioXcel Therapeutics, Inc.
Renewal 2023: BioXcel Therapeutics - QMS - 25 users
4. Negotiation
Q4-2023
95
262
1/12/2023
1/18/2022
Sales
Subscription
0015000002Ijr2RAAR
0015000002Ijr2RAAR
R&D
0015000002Ijr2R
BioXcel Therapeutics
309
1/12/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
BioXcel Therapeutics, Inc.
Renewal 2023: BioXcel_LearnGxP_ELA 200
4. Negotiation
Q4-2023
95
170
1/12/2023
4/20/2022
Sales
Subscription
0015000002Ijr2RAAR
0015000002Ijr2RAAR
R&D
0015000002Ijr2R
BioXcel Therapeutics
310
1/12/2023
EU Sales User - R&D SMB
Robert Everts
Confo Therapeutics NV
Renewal 2023: Confo Therapeutics -EU - QualityDocs 10 Full & 68 RO users
4. Negotiation
Q4-2023
95
268
1/12/2023
1/12/2022
Subscription
0012J00002OMsKnQAL
0012J00002OMsKnQAL
R&D
0012J00002OMsKn
Confo Therapeutics
311
1/14/2023
US Sales User - R&D SMB
Jared Steinberg
Jonathan Waldvogel
Kaleido Biosciences
Renewal 2023: Kaleido Biosciences- QDocs- etMF
1. Prospecting
Q4-2023
0
266
1/14/2023
1/14/2022
Sales
Subscription
0015000001TUnoVAAT
0015000001TUnoVAAT
R&D
0015000001TUnoV
Kaleido Biosciences, Inc.
312
1/17/2023
Asia Pac Sales User - R&D SMB
Sizemore Lee
Samsung BioLogics Co., Ltd.
Renewal 2023: Samsung Biologics_KR_QD_QM_External User Liesne
3. Proposal
Q4-2023
95
263
1/17/2023
1/17/2022
Subscription
0015000001IeeNHAAZ
0015000001IeeNHAAZ
R&D
0015000001IeeNH
Samsung Bioepis
313
1/18/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
TG Therapeutics, Inc.
Renewal 2023: TG Therapeutics - QualityDocs
1. Prospecting
Q4-2023
10
262
1/18/2023
1/18/2022
Subscription
0015000000dbgxqAAA
0015000000dbgxqAAA
R&D
0015000000dbgxq
TG Therapeutics, Inc.
314
1/21/2023
US Sales User - R&D ENT
Chris McShea
Acceleron Pharma Inc.
Renewal 2023: Acceleron- Quality
4. Negotiation
Q4-2023
60
259
1/21/2023
1/21/2022
Sales
Subscription
0015000000Lq8AVAAZ
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0015000000Lq8AV
0012J00002LPcIz
Acceleron Pharma Inc.
315
1/21/2023
EU Sales User - CDMS
Georg Schumm
European Organisation for Research and Treatment of Cancer
Renewal 2023: EORTC - Safety ELA Yr 2 of 3 - 5000 cases (Renewal) - EU + ramp
4. Negotiation
Q4-2023
95
259
1/21/2023
1/21/2022
Sales
Subscription
0015000000wyMo2AAE
0015000000wyMo2AAE
R&D
0015000000wyMo2
EORTC
316
1/21/2023
EU Sales User - CDMS
Georg Schumm
European Organisation for Research and Treatment of Cancer
Renewal 2023: EORTC - ELA SSU, CTMS & eTMF -70 studies - year 2 - Renewal + Ramp
4. Negotiation
Q4-2023
95
259
1/21/2023
1/21/2022
Sales
Subscription
0015000000wyMo2AAE
0015000000wyMo2AAE
R&D
0015000000wyMo2
EORTC
317
1/24/2023
Asia Pac Sales User - R&D SMB
Sizemore Lee
Samsung BioLogics Co., Ltd.
Renewal 2023: Samsung Biologics QualitySuite ELA5000
3. Proposal
Q4-2023
95
256
1/24/2023
1/24/2022
Subscription
0015000001IeeNHAAZ
0015000001IeeNHAAZ
R&D
0015000001IeeNH
Samsung Bioepis
318
1/25/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
CG Oncology, Inc
Renewal 2023: CG Oncology - Vault QualityDocs and Vault Training -50 ELA
4. Negotiation
Q4-2023
95
255
1/25/2023
1/25/2022
Subscription
0012J00002PxlbEQAR
0012J00002PxlbEQAR
R&D
0012J00002PxlbE
CG Oncology, Inc
319
1/25/2023
EU Sales User - R&D SMB
Anastasiia Diatchyk
Santhera Pharmaceuticals (Switzerland) Ltd
Renewal 2023: Santhera - Vault QMS 25 users + 5 QDocs
3. Proposal
Q4-2023
80
255
1/25/2023
1/25/2022
Other
Subscription
0015000000ePgW0AAK
0015000000ePgW0AAK
R&D
0015000000ePgW0
Santhera Pharmaceuticals Holding AG
320
1/26/2023
EU Sales User - R&D SMB
Davide Pesenti
Recordati S.P.A.
Renewal 2023: Recordati Add on Training for HQ- 82 Learner
4. Negotiation
Q4-2023
95
254
1/26/2023
1/26/2022
Sales
Subscription
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0015000000VSdDe
EUSA Pharma
321
1/28/2023
EU Sales User - R&D SMB
Dusan Saska
GW Research Limited
Renewal Feb 2023: GW Pharma QualityDocs 6 months courtesy for migration access
4. Negotiation
Q4-2023
95
47
1/28/2023
8/22/2022
Subscription
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
322
1/29/2023
US Sales User - MedTech ENT
Bryan Federici
Wright Medical Technology, Inc.
Renewal 2023: Wright Medical - eTMF renewal - 17 active
4. Negotiation
Q4-2023
95
219
1/29/2023
3/2/2022
Subscription
0015000000Lq8EoAAJ
0012J00002MKPWRQA5
0012J00002MKPWRQA5
0012J00002MKPWRQA5
R&D
0015000000Lq8Eo
0012J00002MKPWR
Wright Medical Technology, Inc.
323
1/31/2023
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Celularity, Inc.
Renewal 2023: Celularity, Inc._Vault Quality Suite & Clinical
4. Negotiation
Q4-2023
95
249
1/31/2023
1/31/2022
Sales
Subscription
0015000001eMTROAA4
0015000001eMTROAA4
R&D
0015000001eMTRO
Celularity, Inc.
324
1/31/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedX Vault QualityDocs and Training
1. Prospecting
Q4-2023
10
249
1/31/2023
1/31/2022
Sales
Subscription
0015000001EIny5AAD
0015000001EIny5AAD
R&D
0015000001EIny5
Mimedx Group
325
1/31/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal 2023: Myovant Sciences - RIM
4. Negotiation
Q4-2023
95
249
1/31/2023
1/31/2022
Sales
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
326
1/31/2023
EU Sales User - R&D ENT
Jürgen Grampp
Novartis Gene Therapies, Inc.
Renewal 2023: AveXis - eTMF renewal
4. Negotiation
Q4-2023
10
249
1/31/2023
1/31/2022
Sales
Subscription
0015000001IHLa0AAH
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0015000001IHLa0
001500000133m4p
The Medicines Company
327
1/31/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2023: Spark Therapeutics Vault Submissions
4. Negotiation
Q4-2023
95
249
1/31/2023
1/31/2022
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
328
1/31/2023
US Sales User - Commercial ENT
Stefan Jahnecke
Elanco US Inc.
Renewal 2023: Elanco - QualityDocs & QMS ELA
4. Negotiation
Q4-2023
80
36
1/31/2023
9/1/2022
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
R&D
0015000000KQOA1
0012J00002MKyhe
Elanco Animal Health Inc.
329
1/31/2023
US Sales User - Commercial ENT
Stefan Jahnecke
Elanco US Inc.
Renewal 2023: Elanco RIM
4. Negotiation
Q4-2023
80
36
1/31/2023
9/1/2022
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
R&D
0015000000KQOA1
0012J00002MKyhe
Elanco Animal Health Inc.
330
2/1/2023
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2023: Abbott ARDx - NA - RIM - Publishing
2. Discovery
Q1-2024
98
276
2/1/2023
1/4/2022
Sales
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
331
2/1/2023
Asia Pac Sales User - R&D SMB
Sizemore Lee
Samsung Bioepis Co.,Ltd
Renewal 2023: SBE Vault QMS
Closed Won
Q1-2024
100
716
2/1/2023
2/15/2021
Renewal
0015000001XqSccAAF
0015000001IeeNHAAZ
0015000001IeeNHAAZ
0015000001IeeNHAAZ
QMS
Vault
R&D
0015000001XqScc
0015000001IeeNH
Samsung Bioepis
332
2/1/2023
Operations
Kathy Clawson
Cognizant
Renewal 2023: Cognizant-RENEWAL Vault Platform-BPASS
4. Negotiation
Q1-2024
95
220
2/1/2023
3/1/2022
Subscription
0012J00002aBpFVQA0
0012J00002aBpFVQA0
R&D
0012J00002aBpFV
Cognizant Technology Solutions US
333
2/1/2023
EU Sales User - R&D SMB
Katrine Bødker Christensen
Oncopeptides AB
Renewal 2023: Oncopeptides Safety
4. Negotiation
Q1-2024
99
246
2/1/2023
2/3/2022
Sales
Subscription
0015000001RQkXdAAL
0015000001RQkXdAAL
R&D
0015000001RQkXd
Oncopeptides AB
334
2/1/2023
US Sales User - R&D ENT
Lori Thorell
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson eTMF - Med Tech/Device
4. Negotiation
Q1-2024
95
214
2/1/2023
3/7/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
335
2/1/2023
US Sales User - R&D ENT
Lori Thorell
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson eTMF - Pharma
4. Negotiation
Q1-2024
95
214
2/1/2023
3/7/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
336
2/2/2023
US Sales User - CRO
Joel Evans
Syneos
Renewal 2023: GSK CH 218220 / SH 7035160
4. Negotiation
Q1-2024
99
274
2/2/2023
1/6/2022
Sales
Subscription
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002MKPWb
Inventiv
337
2/2/2023
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Precigen, Inc.
Renewal 2023: Precigen - Clinical, Quality & RIM US
4. Negotiation
Q1-2024
95
247
2/2/2023
2/2/2022
Subscription
0015000001Q1vehAAB
0015000001Q1vehAAB
R&D
0015000001Q1veh
Actobio Therapeutics.
338
2/2/2023
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Precigen, Inc.
Renewal 2023: Precigen - Clinical, Quality & RIM EU
4. Negotiation
Q1-2024
95
247
2/2/2023
2/2/2022
Subscription
0015000001Q1vehAAB
0015000001Q1vehAAB
R&D
0015000001Q1veh
Actobio Therapeutics.
339
2/3/2023
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
VYNE Therapeutics Inc.
Renewal 2023: VYNE Pharmaceuticals - Vault QualityDocs/QMS/Training 200 Employee ELA
2. Discovery
Q1-2024
20
246
2/3/2023
2/3/2022
Subscription
0015000000ePgS0AAK
0015000000ePgS0AAK
R&D
0015000000ePgS0
VYNE Pharmaceuticals Inc.
340
2/4/2023
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
Scynexis, Inc.
Renewal 2023: Scynexis (New Logo) QualityDocs
4. Negotiation
Q1-2024
95
245
2/4/2023
2/4/2022
Subscription
0015000000iSC2xAAG
0015000000iSC2xAAG
R&D
0015000000iSC2x
Scynexis, Inc.
341
2/7/2023
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
TherapeuticsMD, Inc.
Renewal 2023: TherapeuticsMD Vault Renewals
4. Negotiation
Q1-2024
95
242
2/7/2023
2/7/2022
Subscription
0015000000dbU1sAAE
0015000000dbU1sAAE
R&D
0015000000dbU1s
TherapeuticsMD, Inc
342
2/7/2023
EU Sales User - MedTech ENT
Ronan McIntyre
Galvani Bioelectronics Limited
Renewal 2023: Galvani eTMF
4. Negotiation
Q1-2024
95
242
2/7/2023
2/7/2022
Subscription
0015000001UYFFrAAP
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000001UYFFr
0012J00002LPpFr
Tesaro, Inc.
343
2/8/2023
US Sales User - R&D SMB
Julie Bolger
Ernie Chin
Amarin Pharma Inc.
Renewal 2023: Amarin Corp_Vault eTMF Archive
4. Negotiation
Q1-2024
95
241
2/8/2023
2/8/2022
Subscription
0015000000UlZyYAAV
0015000000MMajDAAT
0015000000MMajDAAT
0015000000MMajDAAT
R&D
0015000000UlZyY
0015000000MMajD
Amarin Corporation (US Headquarters)
344
2/8/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Sorrento Therapeutics, Inc.
Renewal 2023: Sorrento Therapeutics, Inc. - Vault Submissions Publishing
4. Negotiation
Q1-2024
95
241
2/8/2023
2/8/2022
Sales
Subscription
00150000013SNjAAAW
00150000013SNjAAAW
R&D
00150000013SNjA
Sorrento Therapeutics, Inc.
345
2/9/2023
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2023: Arcturus Therapeutics - Vault Subs 200 ELA & 10 SubsA
4. Negotiation
Q1-2024
90
240
2/9/2023
2/9/2022
Sales
Subscription
0015000000r8H7sAAE
0015000000r8H7sAAE
R&D
0015000000r8H7s
Arcturus Therapeutics, Inc.
346
2/9/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
WAVE Life Sciences Ltd.
Renewal 2023: Wave Life Sciences - Quality - ELA 300
4. Negotiation
Q1-2024
95
240
2/9/2023
2/9/2022
Sales
Subscription
001500000189NO7AAM
001500000189NO7AAM
R&D
001500000189NO7
Wave Life Sciences
347
2/9/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
WAVE Life Sciences Ltd.
Renewal 2023: Wave Life Sciences- Submissions & Archive Superseding Renewal 2020
4. Negotiation
Q1-2024
95
240
2/9/2023
2/9/2022
Subscription
001500000189NO7AAM
001500000189NO7AAM
R&D
001500000189NO7
Wave Life Sciences
348
2/11/2023
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
Cornerstone Pharmaceuticals, Inc.
Renewal 2023: Rafael Pharmaceuticals_Vault QualityDocs & Training
4. Negotiation
Q1-2024
95
238
2/11/2023
2/11/2022
Subscription
0015000001XqkUdAAJ
0015000001XqkUdAAJ
R&D
0015000001XqkUd
Cornerstone Pharmaceuticals
349
2/14/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2023: Vir Bio - Publishing - 300 submissions per year
4. Negotiation
Q1-2024
95
235
2/14/2023
2/14/2022
Sales
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
350
2/14/2023
US Sales User - R&D ENT
Lori Thorell
J&J Pharmaceuticals
Renewal 2023: J&J SSU
4. Negotiation
Q1-2024
95
214
2/14/2023
3/7/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
351
2/22/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Sio Gene Therapies, Inc
Renewal 2023: SIO Gene Therapies - QualityDocs, Training, & QMS
4. Negotiation
Q1-2024
95
227
2/22/2023
2/22/2022
Sales
Subscription
00150000017P4xoAAC
00150000017P4xoAAC
R&D
00150000017P4xo
SIO Gene Therapies Inc
352
2/23/2023
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Allena Pharmaceuticals, Inc.
Renewal 2023: Allena Pharmaceuticals - QualityDocs
4. Negotiation
Q1-2024
95
226
2/23/2023
2/23/2022
Sales
Subscription
0015000000dZnT2AAK
0015000000dZnT2AAK
R&D
0015000000dZnT2
Allena Pharmaceuticals, Inc.
353
2/27/2023
JP Sales User - R&D ENT
Sumiko Sagara
Astellas Pharma Inc.
Renewal 2023: Astellas_QDocs__Apr22 - Mar23
4. Negotiation
Q1-2024
95
222
2/27/2023
2/27/2022
Subscription
0015000000Z41oiAAB
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
R&D
0015000000Z41oi
0012J00002bzHrs
Audentes Therapeutics, Inc.
354
2/28/2023
US Sales User - R&D SMB
Russell Moeai
Christopher Mundy
Pliant Therapeutics Inc
Renewal 2023: Pliant - Vault QDocs & Subs/SubsA - 100 ELA, 15 Full, 5 archive
4. Negotiation
Q1-2024
95
221
2/28/2023
2/28/2022
Subscription
0015000001IIwG5AAL
0015000001IIwG5AAL
R&D
0015000001IIwG5
Pliant Therapeutics Inc
355
2/28/2023
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
Kiniksa Pharmaceuticals Corp.
Renewal 2023: Kiniksa Publishing Volume limited 150 and under
4. Negotiation
Q1-2024
95
221
2/28/2023
2/28/2022
Sales
Subscription
0015000001HfFYcAAN
0015000001HfFYcAAN
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
356
3/1/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2023: Lexicon- Non-GxP Quality Docs - Supply Ops Only
4. Negotiation
Q1-2024
95
220
3/1/2023
3/1/2022
Subscription
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
357
3/1/2023
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2023: Abbott ARDx - Site Connect
4. Negotiation
Q1-2024
95
164
3/1/2023
4/26/2022
Sales
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
358
3/1/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
IMVT Corporation
Renewal Apr 2023: IMVT - LearnGxP - ELA200
4. Negotiation
Q1-2024
95
114
3/1/2023
6/15/2022
Sales
Subscription
0012J00002MJC1tQAH
0015000001APsQwAAL
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0012J00002MJC1t
0015000001APsQw
Dermavant Sciences
359
3/1/2023
US Sales User - R&D ENT
Samantha Sykora
Audentes Therapeutics, Inc.
Renewal Apr 2023: Audentes Therapeutics-QMS-300 ELA *
4. Negotiation
Q1-2024
95
71
3/1/2023
7/28/2022
Subscription
0015000000sDkKcAAK
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
R&D
0015000000sDkKc
0012J00002N44Fa
Audentes Therapeutics, Inc.
360
3/1/2023
US Sales User - R&D ENT
Dawn Wang
Takeda Pharmaceuticals U.S.A., Inc.
Renewal 2023: Takeda - Station Manager - Global
4. Negotiation
Q1-2024
95
275
3/1/2023
1/5/2022
Sales
Subscription
0015000000IO28HAAT
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0015000000IO28H
0012J00002MJsv2
Shire Pharmaceuticals Inc.
361
3/1/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Sumitovant Biopharma, Inc.
Renewal 2023: Sumitovant Biopharma - Vault QualityDocs & Training
4. Negotiation
Q1-2024
95
161
3/1/2023
4/29/2022
Subscription
0012J00002OfD5XQAV
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0012J00002OfD5X
0012J00002MKw1c
SUMITOMO DAINIPPON PHARMA CO., LTD.
362
3/1/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Sumitovant Biopharma, Inc.
Renewal Apr 2023: Sumitovant Biopharma - Vault QMS - 25 users
4. Negotiation
Q1-2024
95
127
3/1/2023
6/2/2022
Sales
Subscription
0012J00002OfD5XQAV
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0012J00002OfD5X
0012J00002MKw1c
SUMITOMO DAINIPPON PHARMA CO., LTD.
363
3/3/2023
EU Sales User - R&D SMB
Charlie Williams
EUSA Pharma (UK) Ltd
Renewal 2023: EUSA Pharma (UK) Ltd - Vault Submissions Archive - 15 Users
4. Negotiation
Q1-2024
95
218
3/3/2023
3/3/2022
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
00150000018O5PO
0015000000VSdDe
EUSA Pharma
364
3/3/2023
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
BD - Renewal Yr 2 RIM: Submissions and Submissions Archive
6. Awaiting P.O.
Q1-2024
95
664
3/3/2023
12/12/2020
Sales
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
Submissions; Submissions Archive
Vault
R&D
0012J00002MKF7I
Becton, Dickinson and Company
365
3/7/2023
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Renewal 2023: Turning Point Therapeutics - QualityDocs and Training - ELA 300
4. Negotiation
Q1-2024
95
214
3/7/2023
3/7/2022
Sales
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
366
3/8/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Dermavant Sciences, Inc.
Renewal 2023: Dermavant Sciences - Vault Quality, Training, RIM, Publishing, Safety & eTMF
4. Negotiation
Q1-2024
95
213
3/8/2023
3/8/2022
Subscription
0015000001RO2GEAA1
0015000001APsQwAAL
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0015000001RO2GE
0015000001APsQw
Dermavant Sciences
367
3/8/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Dermavant Sciences, Inc.
Renewal 2023: Dermavant (RV) - 385 eTMF Archive- New
4. Negotiation
Q1-2024
95
213
3/8/2023
3/8/2022
Subscription
0015000001RO2GEAA1
0015000001APsQwAAL
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0015000001RO2GE
0015000001APsQw
Dermavant Sciences
368
3/10/2023
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2023: Sobi BIVV001-001 - SH 7030030
4. Negotiation
Q1-2024
95
211
3/10/2023
3/10/2022
Partner
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
369
3/10/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2023: Checkmate Pharmaceuticals_Vault eTMF
4. Negotiation
Q1-2024
95
182
3/10/2023
4/8/2022
Subscription
0015000001JKFZmAAP
0015000001JKFZmAAP
R&D
0015000001JKFZm
Checkmate Pharmaceuticals, Inc.
370
3/10/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2023: Checkmate Pharmaceuticals_Vault Quality (QDocs & Training)
4. Negotiation
Q1-2024
95
179
3/10/2023
4/11/2022
Subscription
0015000001JKFZmAAP
0015000001JKFZmAAP
R&D
0015000001JKFZm
Checkmate Pharmaceuticals, Inc.
371
3/14/2023
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Vedanta Biosciences, Inc.
Renewal 2023: Vedanta_eTMF Archive
4. Negotiation
Q1-2024
95
178
3/14/2023
4/12/2022
Sales
Subscription
0015000001JGoyaAAD
0015000001JGoyaAAD
R&D
0015000001JGoya
Vedanta Biosciences, Inc.
372
3/14/2023
US Sales User - Safety
Michael Heimann
PharmaLex GmbH
Renewal 2023: PharmaLex-Submissions
4. Negotiation
Q1-2024
95
207
3/14/2023
3/14/2022
Subscription
0015000000npZHPAA2
0015000000npZHPAA2
R&D
0015000000npZHP
PharmaLex GmbH
373
3/15/2023
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
Renewal 2023: Nektar - Vault Subs/Subs A - 20 Full, 14 Archive
4. Negotiation
Q1-2024
95
183
3/15/2023
4/7/2022
Subscription
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
374
3/15/2023
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2023: Abbott ARDx - eTMF, CTMS & Payments
4. Negotiation
Q1-2024
95
179
3/15/2023
4/11/2022
Sales
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
375
3/16/2023
Asia Pac Sales User - R&D ENT
Pradeep Jandhyala
Klinera Global Services
Renewal Apr 2023: KLinera CTMS - 50 Sites
2. Discovery
Q1-2024
80
75
3/16/2023
7/25/2022
Subscription
0012J00002Km1V6QAJ
0012J00002Km1V6QAJ
R&D
0012J00002Km1V6
Klinera Global Services
376
3/17/2023
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
CTI Biopharma Corp.
Renewal 2022: CTI Biopharma - Vault QMS - 25 Users
4. Negotiation
Q1-2024
90
294
3/17/2023
12/17/2021
Other
Subscription
0015000000LzAaGAAV
0015000000LzAaGAAV
R&D
0015000000LzAaG
CTI Biopharma Corp
377
3/17/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Protara Therapeutics, Inc.
Renewal 2023: Protara eTMF archive 43 sites 11 active
4. Negotiation
Q1-2024
95
178
3/17/2023
4/12/2022
Subscription
0012J00002N3aodQAB
0012J00002N3aodQAB
R&D
0012J00002N3aod
Protara Therapeutics
378
3/17/2023
Asia Pac Sales User - R&D SMB
Sizemore Lee
BINEX Co., Ltd.
Renewal 2023: BINEX_KR_QMS_50
4. Negotiation
Q1-2024
95
204
3/17/2023
3/17/2022
Subscription
0015000001nvobmAAA
0015000001nvobmAAA
R&D
0015000001nvobm
BINEX Co., Ltd.
379
3/18/2023
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Turning Point Therapeutics - QualityDocs and Training - ELA 300 (Ramp Yr. 2)
Closed Won
Q1-2024
100
424
3/18/2023
1/18/2022
Sales
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
380
3/22/2023
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2023: GSK 217710 - SH 7032341
4. Negotiation
Q1-2024
95
199
3/22/2023
3/22/2022
Partner
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
381
3/24/2023
EU Sales User - MedTech ENT
Maxime Dufresne
Carmat SA
Renewal 2023: Carmat - eTMF - 20 sites
4. Negotiation
Q1-2024
90
197
3/24/2023
3/24/2022
Subscription
0015000001KLfgvAAD
0015000001KLfgvAAD
R&D
0015000001KLfgv
Carmat SAS
382
3/25/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Renewal Apr 2023: Amylyx - Submissions & Submissions Archive
4. Negotiation
Q1-2024
95
169
3/25/2023
4/21/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
383
3/25/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Renewal 2023: Amylyx - Vault Clinical - eTMF
4. Negotiation
Q1-2024
95
156
3/25/2023
5/4/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
384
3/25/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Renewal Apr 2023: Amylyx - Safety/SafetyDocs
4. Negotiation
Q1-2024
95
73
3/25/2023
7/26/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
385
3/25/2023
EU Sales User - R&D SMB
Katrine Bødker Christensen
Calliditas Therapeutics AB
Renewal 2023: Calliditas Therapeutics AB - eTMF
4. Negotiation
Q1-2024
95
196
3/25/2023
3/25/2022
Sales
Subscription
0015000002GUdjmAAD
0015000002GUdjmAAD
R&D
0015000002GUdjm
Calliditas Therapeutics
386
3/25/2023
EU Sales User - Medtech SMB
Stefan Schloss
Ascensia Diabetes Care Holdings AG
Renewal 2023: Ascensia - Vault RIM
4. Negotiation
Q1-2024
95
196
3/25/2023
3/25/2022
Subscription
0015000001OCsBSAA1
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
R&D
0015000001OCsBS
0012J00002PUCsz
Ascensia Diabetes Care
387
3/25/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Renewal Apr 2023: Amylyx - QMS Add-on - 55 Users
4. Negotiation
Q1-2024
95
3
3/25/2023
10/4/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
388
3/25/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Renewal Apr 2023: Amylyx - QMS
4. Negotiation
Q1-2024
95
3
3/25/2023
10/4/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
389
3/28/2023
US Sales User - R&D ENT
Jon Tenconi
Astellas Pharma Inc.
Renewal 2023: Astellas_Global_Subs_SubArch_eTMF
4. Negotiation
Q1-2024
95
193
3/28/2023
3/28/2022
Subscription
0015000000Z41oiAAB
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
R&D
0015000000Z41oi
0012J00002bzHrs
Audentes Therapeutics, Inc.
390
3/31/2023
US Sales User - R&D SMB
Russell Moeai
Christopher Mundy
Alkahest, Inc.
Renewal 2023: Alkahest-eTMF-24 Active-16 Orphan
4. Negotiation
Q1-2024
95
190
3/31/2023
3/31/2022
Subscription
0015000001JGRKeAAP
0015000001JGRKeAAP
R&D
0015000001JGRKe
Alkahest, Inc.
391
3/31/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
IMVT Corporation
Renewal 2023: Immunovant (RV) - Vault Quality & RIM
4. Negotiation
Q1-2024
95
190
3/31/2023
3/31/2022
Subscription
0012J00002MJC1tQAH
0015000001APsQwAAL
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0012J00002MJC1t
0015000001APsQw
Dermavant Sciences
392
3/31/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
IMVT Corporation
Renewal 2023: Immunovant (RV) - Subs
4. Negotiation
Q1-2024
95
190
3/31/2023
3/31/2022
Subscription
0012J00002MJC1tQAH
0015000001APsQwAAL
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0012J00002MJC1t
0015000001APsQw
Dermavant Sciences
393
3/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2023: Vir Bio - Vault eTMF - 61 Archive Sites
4. Negotiation
Q1-2024
95
178
3/31/2023
4/12/2022
Sales
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
394
3/31/2023
US Sales User - R&D SMB
Jared Steinberg
Jonathan Waldvogel
Angion Biomedica Corp.
Renewal 2023: Angion QualityDocs
4. Negotiation
Q1-2024
95
170
3/31/2023
4/20/2022
Subscription
0015000001IHjoaAAD
0015000001IHjoaAAD
R&D
0015000001IHjoa
Angion Biomedica Corp.
395
3/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2023: Vir Bio RIM
4. Negotiation
Q1-2024
95
162
3/31/2023
4/28/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
396
3/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2023: Vir Bio QualityDocs & Training
4. Negotiation
Q1-2024
95
162
3/31/2023
4/28/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
397
3/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2023: Vir Bio QMS - 100 Users
4. Negotiation
Q1-2024
95
158
3/31/2023
5/2/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
398
3/31/2023
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
Alimera Sciences, Inc.
Renewal 2023: Alimera RIM + QualityDocs ELA
4. Negotiation
Q1-2024
95
155
3/31/2023
5/5/2022
Subscription
0015000000QYShhAAH
0015000000QYShhAAH
R&D
0015000000QYShh
Alimera Sciences, Inc.
399
3/31/2023
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2023: G1-Sub-Quality-QMS-eTMF-Training- Platform
4. Negotiation
Q1-2024
95
136
3/31/2023
5/24/2022
Subscription
00150000019CZTNAA4
00150000019CZTNAA4
R&D
00150000019CZTN
G1 Therapeutics, Inc.
400
3/31/2023
US Sales User - R&D ENT
Greg Boudreau
Millennium Pharmaceuticals
Renewal:Takeda Pharma - RIM - Global ELA Year 4
Closed Won
Q1-2024
100
954
3/31/2023
8/19/2020
Sales
Subscription
0015000000IO1EFAA1
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000IO1EF
0012J00002LPydA
Shire Pharmaceuticals Inc.
401
3/31/2023
US Sales User - R&D ENT
Greg Boudreau
Takeda Development Center Americas, Inc.
Renewal 2023: Takeda - eTMF ELA Period 4 Global
5. Contracting
Q1-2024
99
193
3/31/2023
3/28/2022
Sales
Subscription
0012J00002aXg5vQAC
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002aXg5v
0012J00002MJsv2
Shire Pharmaceuticals Inc.
402
3/31/2023
EU Sales User - R&D ENT
Katrien Mesotten
Kiadis Pharma Netherlands BV
Renewal 2023: Kiadis Pharma - ELA 200 QD & 45 users QMS
4. Negotiation
Q1-2024
95
150
3/31/2023
5/10/2022
Subscription
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
R&D
00150000010hIes
0015000001TVjdf
Bioverativ, Inc.
403
3/31/2023
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2023: Abbott Vascular LATAM/CALA
4. Negotiation
Q1-2024
95
175
3/31/2023
4/15/2022
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
404
4/1/2023
US Sales User - R&D SMB
Julie Bolger
Ernie Chin
Amarin Corporation
Renewal 2023: FY23- Amarin Pharma - QMS
5. Contracting
Q1-2024
98
273
4/1/2023
1/7/2022
Sales
Subscription
0015000000MMajDAAT
0015000000MMajDAAT
R&D
0015000000MMajD
Amarin Corporation (US Headquarters)
405
4/1/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
IMVT Corporation
Renewal 2023: Immunovant (RV) - Vault Quality & Training
4. Negotiation
Q1-2024
95
189
4/1/2023
4/1/2022
Subscription
0012J00002MJC1tQAH
0015000001APsQwAAL
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0012J00002MJC1t
0015000001APsQw
Dermavant Sciences
406
4/1/2023
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal 2023: CATO SMS - QD QMS VT ELA 2000
4. Negotiation
Q1-2024
95
184
4/1/2023
4/6/2022
Subscription
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000htJv3
Pharm-Olam International, LLC
407
4/1/2023
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2023: St Jude CRH - RIM Suite (Subs, SubsA, Pub)
4. Negotiation
Q1-2024
90
170
4/1/2023
4/20/2022
Subscription
00150000014RszdAAC
00150000014RszdAAC
R&D
00150000014Rszd
St. Jude Children's Research Hospital
408
4/1/2023
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2023:Abbott - China - Separate Cost Center
4. Negotiation
Q1-2024
98
169
4/1/2023
4/21/2022
Sales
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
409
4/1/2023
EU Sales User - CDMS
Georg Schumm
European Organisation for Research and Treatment of Cancer
EORTC - ELA Safety - 5,000 cases - New - EU - Year 3 Renewal + Ramp
6. Awaiting P.O.
Q1-2024
95
659
4/1/2023
12/17/2020
Renewal
0015000000wyMo2AAE
0015000000wyMo2AAE
Vault Safety
Vault
R&D
0015000000wyMo2
EORTC
410
4/1/2023
EU Sales User - CDMS
Georg Schumm
European Organisation for Research and Treatment of Cancer
EORTC - ELA SSU, CTMS & eTMF -70 studies - year 3 - Renewal + Ramp
6. Awaiting P.O.
Q1-2024
99
603
4/1/2023
2/11/2021
Renewal
0015000000wyMo2AAE
0015000000wyMo2AAE
CTMS; eTMF; Study Startup
Vault
R&D
0015000000wyMo2
EORTC
411
4/2/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Prolong Pharmaceuticals, LLC
Renewal May 2023: Prolong - Vault QualityDocs,QMS
4. Negotiation
Q1-2024
95
128
4/2/2023
6/1/2022
Subscription
0015000000bhOKvAAM
0015000000bhOKvAAM
R&D
0015000000bhOKv
Prolong Pharmaceuticals, LLC
412
4/6/2023
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
Kiniksa Pharmaceuticals Corp.
Renewal 2023: Kiniksa- RIM
4. Negotiation
Q1-2024
95
162
4/6/2023
4/28/2022
Subscription
0015000001HfFYcAAN
0015000001HfFYcAAN
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
413
4/7/2023
JP Sales User - R&D ENT
Junichiro Tomoda
Sumitomo Pharma Co., Ltd.
Renewal 2023: Dainippon Sumitomo Global Submission 990 users
4. Negotiation
Q1-2024
95
184
4/7/2023
4/6/2022
Subscription
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000000ORqoN
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
414
4/15/2023
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2023: Omeros Vault QualityDocs - 300 ELA
4. Negotiation
Q1-2024
95
148
4/15/2023
5/12/2022
Subscription
0015000000aQgjUAAS
0015000000aQgjUAAS
R&D
0015000000aQgjU
Omeros Corporation
415
4/15/2023
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2023: Omeros - Sub/SubA - 10 Full, 10 Archive
4. Negotiation
Q1-2024
95
148
4/15/2023
5/12/2022
Subscription
0015000000aQgjUAAS
0015000000aQgjUAAS
R&D
0015000000aQgjU
Omeros Corporation
416
4/15/2023
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2023: Omeros - QMS - 50 Full Users
4. Negotiation
Q1-2024
95
148
4/15/2023
5/12/2022
Subscription
0015000000aQgjUAAS
0015000000aQgjUAAS
R&D
0015000000aQgjU
Omeros Corporation
417
4/15/2023
US Sales User - CRO
Greyson McGrail
Katie Tipton
Spaulding Clinical Research, LLC
Renewal 2023: Spaulding Clinical Research - eTMF
4. Negotiation
Q1-2024
95
140
4/15/2023
5/20/2022
Subscription
00150000015LXQaAAO
00150000015LXQaAAO
R&D
00150000015LXQa
Spaulding Clinical Research, LLC
418
4/16/2023
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
Alimera Sciences, Inc.
Renewal 2023: Alimera Training & QMS NA
4. Negotiation
Q1-2024
95
297
4/16/2023
12/14/2021
Sales
Subscription
0015000000QYShhAAH
0015000000QYShhAAH
R&D
0015000000QYShh
Alimera Sciences, Inc.
419
4/16/2023
US Sales User - R&D SMB
Emily Rollet
Ernie Chin
Purdue Pharma L.P.
Renewal 2023: Purdue - Vault QMS - 165 Users PUPM
4. Negotiation
Q1-2024
95
171
4/16/2023
4/19/2022
Sales
Subscription
0015000000IO284AAD
0015000000IO284AAD
R&D
0015000000IO284
Purdue Pharma L.P.
420
4/30/2023
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
Renewal 2023: Nektar Vault eTMF - 401 Active, 65 Archive
4. Negotiation
Q1-2024
80
129
4/30/2023
5/31/2022
Subscription
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
421
5/1/2023
US Sales User - MedTech SMB
Carla Foley
New Erie Scientific LLC
Renewal 2023: Epredia QDocs and Training for October 2020 Add-on
3. Proposal
Q2-2024
90
737
5/1/2023
10/1/2020
Renewal
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
QualityDocs
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
422
5/1/2023
US Sales User - MedTech SMB
Carla Foley
New Erie Scientific LLC
Renewal 2023: Epredia Vault QMS, Training, & QDocs
3. Proposal
Q2-2024
50
569
5/1/2023
3/17/2021
Renewal
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
QMS
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
423
5/1/2023
US Sales User - R&D SMB
Seth Fox
David Florez
Coherus BioSciences, Inc.
Renewal 2023: Coherus Biosciences - eTMF - 15 Active / 21 Archive Sites
4. Negotiation
Q2-2024
95
186
5/1/2023
4/4/2022
Subscription
0015000000tq1wMAAQ
0015000000tq1wMAAQ
R&D
0015000000tq1wM
Coherus Biosciences, Inc.
424
5/1/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2023: Lexicon eTMF
4. Negotiation
Q2-2024
95
156
5/1/2023
5/4/2022
Subscription
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
425
5/1/2023
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2023: Supernus Pharma - Vault eTMF, eTMF Archive, CTMS, & Payments
4. Negotiation
Q2-2024
95
155
5/1/2023
5/5/2022
Sales
Subscription
0015000000PiLnMAAV
0015000000PiLnMAAV
R&D
0015000000PiLnM
Supernus Pharmaceuticals, Inc.
426
5/1/2023
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Kodiak Sciences
Renewal 2023: Kodiak Sciences - Vault eTMF / CTMS - Sites 15
4. Negotiation
Q2-2024
95
150
5/1/2023
5/10/2022
Sales
Subscription
0015000000bhNQvAAM
0015000000bhNQvAAM
R&D
0015000000bhNQv
Kodiak Sciences
427
5/1/2023
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2023: Jazz Pharma - Vault CTMS
4. Negotiation
Q2-2024
95
149
5/1/2023
5/11/2022
Sales
Subscription
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
428
5/1/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Bellicum Pharmaceuticals Inc.
Renewal 2023: Bellicum Vault- Qdocs & eTMF
4. Negotiation
Q2-2024
95
137
5/1/2023
5/23/2022
Subscription
0015000000bhOLMAA2
0015000000bhOLMAA2
R&D
0015000000bhOLM
Bellicum Pharmaceuticals, Inc.
429
5/1/2023
US Sales User - MedTech ENT
Casey Davidson
International Partnership for Microbicides, Inc.
Renewal 2023: IPM - eTMF - 30 Sites
4. Negotiation
Q2-2024
95
134
5/1/2023
5/26/2022
Sales
Subscription
0015000001RFZmPAAX
0015000001RFZmPAAX
R&D
0015000001RFZmP
International Partnership for Microbicides
430
5/1/2023
US Sales User - R&D SMB
Marta Considine
Adam De Oliveira
Avalo Therapeutics, Inc.
Renewal Jun 2023: Avalo Tx - Subs Archive, Training & QDocs PUPM to ELA 100 conversion
4. Negotiation
Q2-2024
95
133
5/1/2023
5/27/2022
Subscription
0015000000htJuFAAU
0015000000htJuFAAU
R&D
0015000000htJuF
Cerecor
431
5/1/2023
US Sales User - R&D SMB
Seth Fox
David Florez
Coherus BioSciences, Inc.
Renewal Jun 2023: Coherus - RIM (Subs/SubsA)
4. Negotiation
Q2-2024
95
123
5/1/2023
6/6/2022
Subscription
0015000000tq1wMAAQ
0015000000tq1wMAAQ
R&D
0015000000tq1wM
Coherus Biosciences, Inc.
432
5/1/2023
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal Jun 2023: Jazz Pharmaceuticals - Vault eTMF
4. Negotiation
Q2-2024
95
79
5/1/2023
7/20/2022
Subscription
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
433
5/1/2023
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Strongbridge U.S. Inc.
Renewal Jun 2023: Strongbridge Quality (QualityDocs & QMS)
4. Negotiation
Q2-2024
95
70
5/1/2023
7/29/2022
Subscription
00150000016BpEmAAK
00150000018Qz0AAAS
00150000018Qz0AAAS
00150000018Qz0AAAS
R&D
00150000016BpEm
00150000018Qz0A
Strongbridge Biopharma plc
434
5/1/2023
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2023: BIKEN QualityDocs
4. Negotiation
Q2-2024
95
137
5/1/2023
5/23/2022
Subscription
0015000001nyfi1AAA
0015000001nyfi1AAA
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
435
5/1/2023
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2023: BIKEN eTMF 43 Sites
4. Negotiation
Q2-2024
95
137
5/1/2023
5/23/2022
Subscription
0015000001nyfi1AAA
0015000001nyfi1AAA
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
436
5/1/2023
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal Jun 2023: Biken CTMS 32 sites - Japan Local Deal
4. Negotiation
Q2-2024
95
38
5/1/2023
8/31/2022
Sales
Subscription
0015000001nyfi1AAA
0015000001nyfi1AAA
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
437
5/1/2023
US Sales User - Safety
Michael Heimann
SOTIO Biotech a.s.
Renewal 2023: 2022: Sotio Biotech - Safety
4. Negotiation
Q2-2024
95
161
5/1/2023
4/29/2022
Sales
Subscription
0012J00002X2YJBQA3
0015000000ePOfRAAW
0015000000ePOfRAAW
0015000000ePOfRAAW
R&D
0012J00002X2YJB
0015000000ePOfR
SCTbio a.s.
438
5/1/2023
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal Jun 2023: GSK Consumer Vault QMS P3 Renewal
6. Awaiting P.O.
Q2-2024
99
121
5/1/2023
6/9/2022
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
439
5/1/2023
LatAm Sales User
Luis Fernandez
Específicos Stendhal S.A de C.V.
Renewal Jun 2023: Stendhal LatAm Registrations 10 Users
4. Negotiation
Q2-2024
95
79
5/1/2023
7/20/2022
Subscription
0015000000fTHSgAAO
0012J00002K4P7SQAV
0012J00002K4P7SQAV
0012J00002K4P7SQAV
R&D
0015000000fTHSg
0012J00002K4P7S
Espec�ficos Stendhal S.A de C.V.
440
5/6/2023
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Kodiak Sciences
Renewal Jun 2023: Kodiak Sciences - Vault Subs / Subs A / Subs Publishing -20 FU, SA 12, 100 Pub Vol Limit
4. Negotiation
Q2-2024
95
122
5/6/2023
6/7/2022
Sales
Subscription
0015000000bhNQvAAM
0015000000bhNQvAAM
R&D
0015000000bhNQv
Kodiak Sciences
441
5/6/2023
EU Sales User - R&D SMB
Hasse Rando
Swedish Orphan Biovitrum AB (publ)
Renewal Jun 2023: SOBI - Quality and Training ELA convert fron PUMP
4. Negotiation
Q2-2024
95
128
5/6/2023
6/1/2022
Sales
Subscription
0015000000OU1qNAAT
0015000000OU1qNAAT
R&D
0015000000OU1qN
Dova Pharmaceuticals, LLC
442
5/12/2023
US Sales User - R&D SMB
Russell Moeai
Christopher Mundy
Parker Institute for Cancer Immunotherapy
Renewal 2023: Parker Institute - QualityDocs_200 ELA & 33 eTMF- Safety
4. Negotiation
Q2-2024
95
175
5/12/2023
4/15/2022
Subscription
0015000001EbYF8AAN
0015000001EbYF8AAN
R&D
0015000001EbYF8
Parker Institute for Cancer Immunotherapy
443
5/13/2023
EU Sales User - R&D SMB
Dusan Saska
GW Research Limited
Renewal Jun 2023: GW eTMF
4. Negotiation
Q2-2024
95
93
5/13/2023
7/6/2022
Subscription
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
444
5/19/2023
US Sales User - R&D SMB
Adam Sybrowsky
David Florez
Societal CDMO
Renewal 2023: Societal CDMO QualityDocs Renewal
4. Negotiation
Q2-2024
95
147
5/19/2023
5/13/2022
Subscription
0015000001P4J8XAAV
0015000001P4J8XAAV
R&D
0015000001P4J8X
Societal CDMO
445
5/31/2023
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2023: Syneos eTMF - 3YR ELA - (Year 3)
Closed Won
Q2-2024
100
700
5/31/2023
6/30/2021
Renewal
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
eTMF
Vault
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
446
5/31/2023
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal 2023: IAVI - eTMF 4 Archive Sites Mult-Year T001 Trial
3. Proposal
Q2-2024
0
463
5/31/2023
7/1/2021
Renewal
00150000019DKfQAAW
00150000019DKfQAAW
eTMF
Vault
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
447
5/31/2023
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Ocugen, Inc.
Renewal 2023: Ocugen - Subs & SubsA
4. Negotiation
Q2-2024
95
154
5/31/2023
5/6/2022
Sales
Subscription
0015000000tFn6fAAC
0015000000tFn6fAAC
R&D
0015000000tFn6f
Ocugen, Inc.
448
5/31/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Arvinas Operations, Inc
Renewal Jul 2023: Arvinas - QDocs & Training & Subs/SubsA
4. Negotiation
Q2-2024
95
127
5/31/2023
6/2/2022
Subscription
0015000001MaGUTAA3
0015000001MaGUTAA3
R&D
0015000001MaGUT
Arvinas
449
5/31/2023
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
Denovo Biopharma LLC
Renewal Jul 2023: Denovo (formerly Tocagen) eTMF, Sub & Archive
4. Negotiation
Q2-2024
95
58
5/31/2023
8/10/2022
Subscription
00150000025afp4AAA
00150000025afp4AAA
R&D
00150000025afp4
Denovo Biopharma LLC
450
5/31/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Arvinas Operations, Inc
Renewal Jul 2023: Arvinas - eTMF - Outsourcing and Archive Minimum
4. Negotiation
Q2-2024
95
42
5/31/2023
8/26/2022
Sales
Subscription
0015000001MaGUTAA3
0015000001MaGUTAA3
R&D
0015000001MaGUT
Arvinas
451
5/31/2023
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal Jul 2023: IAVI - NA - eTMF
4. Negotiation
Q2-2024
95
78
5/31/2023
7/21/2022
Subscription
00150000019DKfQAAW
00150000019DKfQAAW
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
452
5/31/2023
Asia Pac Sales User - R&D ENT
Amber Lee
SillaJen, Inc.
Renewal Jul 2023: Sillajen - Vault QualityDocs - 50 Employee ELA
4. Negotiation
Q2-2024
95
96
5/31/2023
7/3/2022
Subscription
0015000002GVFnkAAH
0015000002GVFnkAAH
R&D
0015000002GVFnk
Sillajen Biotherapeutics, Inc.
453
5/31/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal Jul 2023: MiMedx - Submissions and Submissions Archive
4. Negotiation
Q2-2024
95
86
5/31/2023
7/13/2022
Subscription
0015000001EIny5AAD
0015000001EIny5AAD
R&D
0015000001EIny5
Mimedx Group
454
5/31/2023
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2023: Daiichi Sankyo - CoMET QualityDocs - JP/US/EU
4. Negotiation
Q2-2024
95
171
5/31/2023
4/20/2022
Subscription
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
455
5/31/2023
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2023: Daiichi Sankyo - CoMET eTMF ELA - JP/US/EU
4. Negotiation
Q2-2024
95
163
5/31/2023
4/27/2022
Subscription
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
456
5/31/2023
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal Jul 2023: GSK Biopharma QualityDocs ELA
6. Awaiting P.O.
Q2-2024
99
108
5/31/2023
6/21/2022
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
457
5/31/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal Jul 2023: MiMedx - Vault eTMF, CTMS, & Payments
4. Negotiation
Q2-2024
95
86
5/31/2023
7/13/2022
Subscription
0015000001EIny5AAD
0015000001EIny5AAD
R&D
0015000001EIny5
Mimedx Group
458
6/1/2023
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal Jul 2023: TRI Vault Submissions 7-1-2023
4. Negotiation
Q2-2024
99
80
6/1/2023
7/19/2022
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
459
6/1/2023
EU Sales User - R&D SMB
Jeremy Cottin
ERYTECH Pharma S.A
Renewal 2023: Erytech - QMS - ELA300- Year 3 + ramp
6. Awaiting P.O.
Q2-2024
99
486
6/1/2023
6/8/2021
Sales
Subscription
00150000019s0WQAAY
00150000019s0WQAAY
QMS
Vault
R&D
00150000019s0WQ
Erytech
460
6/8/2023
EU Sales User - R&D SMB
Anastasiia Diatchyk
Auregen BioTherapeutics SA
Renewal 2023: Auregen Biotherapeutics- Quality
4. Negotiation
Q2-2024
95
151
6/8/2023
5/9/2022
Subscription
0015000001XsdfDAAR
0015000001XsdfDAAR
R&D
0015000001XsdfD
Auregen Biotherapeutics SA
461
6/9/2023
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal Jul 2023: Homology RIM
4. Negotiation
Q2-2024
95
93
6/9/2023
7/6/2022
Subscription
0015000001XrfCWAAZ
0015000001XrfCWAAZ
R&D
0015000001XrfCW
Homology Medicines Inc.
462
6/9/2023
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal Jul 2023: Homology Medicines - Quality & Training ELA 200 #NC
4. Negotiation
Q2-2024
95
92
6/9/2023
7/7/2022
Subscription
0015000001XrfCWAAZ
0015000001XrfCWAAZ
R&D
0015000001XrfCW
Homology Medicines Inc.
463
6/9/2023
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal Jul 2023: Homology eTMF
4. Negotiation
Q2-2024
95
63
6/9/2023
8/5/2022
Subscription
0015000001XrfCWAAZ
0015000001XrfCWAAZ
R&D
0015000001XrfCW
Homology Medicines Inc.
464
6/11/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Polynoma LLC
Renewal Jul 2023: Polynoma LLC - QualityDocs 50ELA
4. Negotiation
Q2-2024
95
81
6/11/2023
7/18/2022
Sales
Subscription
0015000000fTTJBAA4
0015000000fTTJBAA4
R&D
0015000000fTTJB
Polynoma LLC
465
6/11/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Sorrento Therapeutics, Inc.
Renewal Jul 2023: Sorrento Therapeutics - Vault Submissions/Submissions Archive
4. Negotiation
Q2-2024
95
74
6/11/2023
7/25/2022
Subscription
00150000013SNjAAAW
00150000013SNjAAAW
R&D
00150000013SNjA
Sorrento Therapeutics, Inc.
466
6/15/2023
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2023: GSK 218407 - SH 7035538
4. Negotiation
Q2-2024
99
199
6/15/2023
3/22/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
467
6/15/2023
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
Kiniksa Pharmaceuticals Corp.
Renewal Jul 2023: Kiniksa Pharmaceuticals - eTMF
4. Negotiation
Q2-2024
95
69
6/15/2023
7/30/2022
Subscription
0015000001HfFYcAAN
0015000001HfFYcAAN
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
468
6/16/2023
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2023: Daiichi Sankyo - CoMET Subs ELA & Subs Archive - JP/US/EU
4. Negotiation
Q2-2024
95
302
6/16/2023
12/9/2021
Subscription
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
469
6/16/2023
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Jul 2023: Medytox_KR_QD & VT_ELA500_Year2
Closed Won
Q2-2024
100
354
6/16/2023
6/27/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
470
6/16/2023
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma Publishing-US/EU-Yr 2 Renewal
Closed Won
Q2-2024
100
627
6/16/2023
9/27/2021
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Submissions Publishing
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
471
6/18/2023
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Jul 2023: BioNTech - Safety - 500 cases Year 1
4. Negotiation
Q2-2024
95
71
6/18/2023
7/28/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
472
6/20/2023
CN Sales User - R&D SMB
Shirley Wang
Suzhou Transcenta Therapeutics Co., Ltd.
Renewal Jun 2023: Transcenta suzhou-China-eTMF-ELA by study
Closed Won
Q2-2024
100
365
6/20/2023
6/20/2022
Sales
Subscription
0012J00002ZZ6bAQAT
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002ZZ6bA
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
473
6/30/2023
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma RIM Suite Y4 Renewal (EU)
Closed Won
Q2-2024
100
1072
6/30/2023
7/23/2020
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
474
6/30/2023
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma RIM Suite Yr 4 Renewal (US)
Closed Won
Q2-2024
100
1072
6/30/2023
7/23/2020
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
475
7/1/2023
US Sales User - R&D SMB
Adam Sybrowsky
David Florez
Societal CDMO
Renewal 2023: Societal CDMO - QMS (Change Control) - ELA 300
4. Negotiation
Q2-2024
95
147
7/1/2023
5/13/2022
Marketing
Subscription
0015000001P4J8XAAV
0015000001P4J8XAAV
R&D
0015000001P4J8X
Societal CDMO
476
7/1/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal Aug 2023: Biocryst Pharmaceuticals - Vault CTMS/eTMF - Orphan Sites
4. Negotiation
Q2-2024
95
52
7/1/2023
8/16/2022
Subscription
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
477
7/1/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal Aug 2023: Biocryst - Submissions & Submissions Archive - ELA400
4. Negotiation
Q2-2024
95
38
7/1/2023
8/30/2022
Subscription
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
478
7/1/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal Aug 2023: Biocryst Pharmaceuticals - QMS & QualityDocs - ELA400
4. Negotiation
Q2-2024
95
38
7/1/2023
8/30/2022
Subscription
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
479
7/1/2023
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal Aug 2023: St Jude CRH Clinical Apps
4. Negotiation
Q2-2024
95
24
7/1/2023
9/13/2022
Subscription
00150000014RszdAAC
00150000014RszdAAC
R&D
00150000014Rszd
St. Jude Children's Research Hospital
480
7/1/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Repertoire Immune Medicines
Renewal Aug 2023: Repertoire - eTMF #NC
4. Negotiation
Q2-2024
95
80
7/1/2023
7/19/2022
Subscription
0012J00002P8I3DQAV
0012J00002P8I3DQAV
R&D
0012J00002P8I3D
Repertoire Immune Medicines
481
7/1/2023
US Sales User - R&D SMB
Emily Rollet
Ernie Chin
Purdue Pharma L.P.
Renewal Aug 2023: Purdue/Imbrium - Vault Submissions - 60 users
4. Negotiation
Q2-2024
95
107
7/1/2023
6/22/2022
Subscription
0015000000IO284AAD
0015000000IO284AAD
R&D
0015000000IO284
Purdue Pharma L.P.
482
7/1/2023
JP Sales User - R&D ENT
Junichiro Tomoda
Sumitomo Pharma Co., Ltd.
Renewal Aug 2023: SMP Clinical QMS 25 users
4. Negotiation
Q2-2024
95
89
7/1/2023
7/10/2022
Subscription
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000000ORqoN
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
483
7/1/2023
Asia Pac Sales User - R&D ENT
Amber Lee
SillaJen, Inc.
Renewal Aug 2023: Sillajen - Vault eTMF & CTMS
4. Negotiation
Q2-2024
95
96
7/1/2023
7/3/2022
Subscription
0015000002GVFnkAAH
0015000002GVFnkAAH
R&D
0015000002GVFnk
Sillajen Biotherapeutics, Inc.
484
7/13/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Nevakar, Inc.
Renewal Aug 2023: Nevakar - Vault RIM
4. Negotiation
Q2-2024
95
58
7/13/2023
8/10/2022
Subscription
0015000001TU8VKAA1
0015000001TU8VKAA1
R&D
0015000001TU8VK
Nevakar, inc.
485
7/15/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Roivant Sciences, Inc.
Renewal Aug 2023: Roivant Sciences - Vault RIM, Quality, eTMF
4. Negotiation
Q2-2024
95
46
7/15/2023
8/22/2022
Subscription
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0015000001APsQw
Dermavant Sciences
486
7/15/2023
US Sales User - R&D SMB
Russell Moeai
Christopher Mundy
Theravance Biopharma US, Inc.
Renewal Aug 2023: Theravance - Subs 20 users/SubsA 10 users
4. Negotiation
Q2-2024
95
45
7/15/2023
8/23/2022
Sales
Subscription
0015000000LX0LMAA1
0015000000LX0LMAA1
R&D
0015000000LX0LM
Theravance Biopharma US, Inc.
487
7/15/2023
US Sales User - R&D SMB
Julie Bolger
Ernie Chin
Amarin Pharma Inc.
Renewal Aug 2023: Amarin Corp_Vault Submissions/Submissions Archive
4. Negotiation
Q2-2024
95
102
7/15/2023
6/27/2022
Subscription
0015000000UlZyYAAV
0015000000MMajDAAT
0015000000MMajDAAT
0015000000MMajDAAT
R&D
0015000000UlZyY
0015000000MMajD
Amarin Corporation (US Headquarters)
488
7/20/2023
US Sales User - R&D ENT
Greg Boudreau
Takeda Development Center Americas, Inc.
Renewal 2023: Takeda Pharma - CTMS_SSU_Payments_Site Connect - Global - ELA Year 2
Closed Won
Q2-2024
100
588
7/20/2023
12/9/2021
Sales
Subscription
0012J00002aXg5vQAC
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002aXg5v
0012J00002MJsv2
Shire Pharmaceuticals Inc.
489
7/21/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
WAVE Life Sciences Ltd.
Renewal Aug 2023: Wave Life Sciences- Contract Management (Platform)
4. Negotiation
Q2-2024
95
49
7/21/2023
8/19/2022
Subscription
001500000189NO7AAM
001500000189NO7AAM
R&D
001500000189NO7
Wave Life Sciences
490
7/28/2023
EU Sales User - R&D SMB
Dusan Saska
Jazz
Renewal Aug 2023: Jazz Pharmaceuticals Vault QualityDocs and QMS ELA 3,500
4. Negotiation
Q2-2024
95
44
7/28/2023
8/24/2022
Sales
Subscription
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
491
7/28/2023
EU Sales User - R&D SMB
Sarah Kemkes
MorphoSys AG
Renewal Aug 2023: Renewal 2022 Morphosys - RIM ELA 1000
4. Negotiation
Q2-2024
95
44
7/28/2023
8/25/2022
Sales
Subscription
0015000000OQ3L7AAL
0015000000OQ3L7AAL
R&D
0015000000OQ3L7
MorphoSys AG
492
7/28/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal Aug 2023: Spark Platform Contracts Management
4. Negotiation
Q2-2024
95
38
7/28/2023
8/30/2022
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
493
7/28/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal Aug 2023: Spark Platform License Add-On: 3 Full Users, 5 Read-Only
4. Negotiation
Q2-2024
95
2
7/28/2023
10/5/2022
Sales
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
494
8/1/2023
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Arcturus Therapeutics, Inc.
Renewal Sep 2023: Arcturus Therapeutics - Vault QualityDocs & Vault Training - 200 ELA
4. Negotiation
Q3-2024
95
43
8/1/2023
8/25/2022
Subscription
0015000000r8H7sAAE
0015000000r8H7sAAE
R&D
0015000000r8H7s
Arcturus Therapeutics, Inc.
495
8/1/2023
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Kodiak Sciences
Renewal Sep 2023: Kodiak Sciences - QualityDocs - 200 ELA
4. Negotiation
Q3-2024
95
40
8/1/2023
8/28/2022
Subscription
0015000000bhNQvAAM
0015000000bhNQvAAM
R&D
0015000000bhNQv
Kodiak Sciences
496
8/1/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal Sep 2023: Lexicon - Safety - 250 active cases
3. Proposal
Q3-2024
90
38
8/1/2023
8/30/2022
Sales
Subscription
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
497
8/1/2023
US Sales User - R&D ENT
Jon Tenconi
Astellas Pharma US LLC
Renewal Sep 2023: Astellas - Issue Management - Active Study License
4. Negotiation
Q3-2024
95
9
8/1/2023
9/28/2022
Subscription
0015000000IO270AAD
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
R&D
0015000000IO270
0012J00002bzHrs
Audentes Therapeutics, Inc.
498
8/1/2023
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2023: BioNTech AG - Quality Suite (Qdocs+QMS+Training)
4. Negotiation
Q3-2024
95
40
8/1/2023
8/28/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
499
8/1/2023
EU Sales User - CDMS
Georg Schumm
European Organisation for Research and Treatment of Cancer
Renewal Sep 2023: EORTC QMS ELA 300
4. Negotiation
Q3-2024
95
107
8/1/2023
6/22/2022
Subscription
0015000000wyMo2AAE
0015000000wyMo2AAE
R&D
0015000000wyMo2
EORTC
500
8/6/2023
EU Sales User - R&D SMB
Jeremy Cottin
ERYTECH Pharma S.A
Renewal Sep 2023: Erytech - QMS - ELA300- Year 1 + ramp
4. Negotiation
Q3-2024
95
110
8/6/2023
6/19/2022
Sales
Subscription
00150000019s0WQAAY
00150000019s0WQAAY
R&D
00150000019s0WQ
Erytech
501
8/11/2023
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Braeburn Inc.
Renewal Sep 2023: Braeburn Vault Submissions/Submissions Archive
4. Negotiation
Q3-2024
95
46
8/11/2023
8/22/2022
Subscription
0015000000jYgnuAAC
0015000000jYgnuAAC
R&D
0015000000jYgnu
Braeburn Inc.
502
8/11/2023
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Vedanta Biosciences, Inc.
Renewal Sep 2023: Vedanta - QualityDocs & Training ELA - QMS 30 Users
4. Negotiation
Q3-2024
95
44
8/11/2023
8/24/2022
Subscription
0015000001JGoyaAAD
0015000001JGoyaAAD
R&D
0015000001JGoya
Vedanta Biosciences, Inc.
503
8/12/2023
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2023: BioNTech SE - eTMF, CTMS, SSU - ELA Year 1
4. Negotiation
Q3-2024
95
31
8/12/2023
9/6/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
504
8/14/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal Sep 2023: Spark - Quality - QMS
4. Negotiation
Q3-2024
95
30
8/14/2023
9/7/2022
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
505
8/14/2023
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal Sep 2023: Spark - NA - eTMF/CTMS Sites - ELA
4. Negotiation
Q3-2024
95
18
8/14/2023
9/19/2022
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
506
8/15/2023
US Sales User - CRO
Greyson McGrail
Katie Tipton
ASH Research Collaborative
Renewal Sep 2023: ASH - eTMF - 52 Sites
4. Negotiation
Q3-2024
95
42
8/15/2023
8/26/2022
Subscription
0012J00002QLRmAQAX
0012J00002QLRmAQAX
R&D
0012J00002QLRmA
ASH Research Collaborative
507
8/15/2023
US Sales User - R&D SMB
Justin Zaccone
Ernie Chin
Sumitomo Pharma Oncology, Inc.
Renewal Sep 2023: SDPO- eTMF & Platform Renewal
4. Negotiation
Q3-2024
95
21
8/15/2023
9/16/2022
Subscription
0015000000ph6mWAAQ
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000000ph6mW
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
508
8/18/2023
EU Sales User - R&D ENT
Fabian Metz
BIONTECH US INC.
Renewal Sep 2023: BioNTech US - eTMF - migration courtesy access
4. Negotiation
Q3-2024
95
33
8/18/2023
9/5/2022
Subscription
0015000001HE1PXAA1
0015000001HENG5AAP
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HE1PX
0015000001HENG5
BIONTECH US INC.
509
8/28/2023
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2023: Jazz - Qdocs, QMS (Placeholder)
1. Prospecting
Q3-2024
80
99
8/28/2023
6/30/2022
Sales
Subscription
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
510
8/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal Oct 2023: Calico Life Sciences - QD/VT - 4 RO, 4 learner (add-on from bucket)
4. Negotiation
Q3-2024
95
52
8/31/2023
8/16/2022
Sales
Subscription
0015000001nxYfoAAE
0015000001nxYfoAAE
R&D
0015000001nxYfo
Calico Life Sciences LLC
511
8/31/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Tiziana Life Sciences plc
Renewal Oct 2023: Tiziana Life Sciences_Vault RIM (Submissions/Submissions Archive)
4. Negotiation
Q3-2024
95
49
8/31/2023
8/19/2022
Subscription
0012J00002LQ6AYQA1
0012J00002LQ6AYQA1
R&D
0012J00002LQ6AY
Tiziana Life Sciences plc
512
8/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal Oct 2023: Calico Life Sciences - QualityDocs + Training
4. Negotiation
Q3-2024
95
35
8/31/2023
9/2/2022
Subscription
0015000001nxYfoAAE
0015000001nxYfoAAE
R&D
0015000001nxYfo
Calico Life Sciences LLC
513
8/31/2023
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal Oct 2023: Xeris - eTMF Renewal
4. Negotiation
Q3-2024
95
31
8/31/2023
9/6/2022
Subscription
00150000018Qz0AAAS
00150000018Qz0AAAS
R&D
00150000018Qz0A
Strongbridge Biopharma plc
514
8/31/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal Oct 2023: Black Diamond Therapeutics_Vault eTMF
4. Negotiation
Q3-2024
95
30
8/31/2023
9/7/2022
Subscription
0015000002IiNnuAAF
0015000002IiNnuAAF
R&D
0015000002IiNnu
Black Diamond Therapeutics
515
8/31/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
FerGene Inc.
Renewal Oct 2023: FerGene- Qdocs, Training, QMS, Subs & SubA #NC
4. Negotiation
Q3-2024
95
17
8/31/2023
9/20/2022
Subscription
0012J00002OdrDNQAZ
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0012J00002OdrDN
0012J00002MKF7X
FerGene
516
8/31/2023
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal Oct 2023: Black Diamond_Vault RIM (Submissions/Publishing/Submissions Archive) #NC
4. Negotiation
Q3-2024
95
9
8/31/2023
9/28/2022
Subscription
0015000002IiNnuAAF
0015000002IiNnuAAF
R&D
0015000002IiNnu
Black Diamond Therapeutics
517
8/31/2023
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Tiziana Life Sciences plc
Renewal Oct 2023: Tiziana Life Sciences - Vault QualityDocs - 10 Users
4. Negotiation
Q3-2024
95
63
8/31/2023
8/5/2022
Sales
Subscription
0012J00002LQ6AYQA1
0012J00002LQ6AYQA1
R&D
0012J00002LQ6AY
Tiziana Life Sciences plc
518
8/31/2023
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Renewal - Roche Pharma eTMF/CTMS Y4 ramp (EU+US)
Closed Won
Q3-2024
100
1113
8/31/2023
8/13/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
519
8/31/2023
EU Sales User - R&D SMB
Reto Flury
Ferring International Center SA
Renewal Oct 2023: Ferring - Vault Registrations - PUPM Year 2
4. Negotiation
Q3-2024
95
44
8/31/2023
8/24/2022
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
520
8/31/2023
EU Sales User - R&D SMB
Katrine Bødker Christensen
Calliditas Therapeutics AB
Renewal Oct 2023: Calliditas Therapeutics AB - QD ELA 200 Subs
4. Negotiation
Q3-2024
95
30
8/31/2023
9/8/2022
Subscription
0015000002GUdjmAAD
0015000002GUdjmAAD
R&D
0015000002GUdjm
Calliditas Therapeutics
521
8/31/2023
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
HilleVax, Inc.
Renewal Oct 2023: HilleVax eTMF Archive
4. Negotiation
Q3-2024
95
15
8/31/2023
9/22/2022
Subscription
0012J00002U6WwuQAF
0012J00002U6WwuQAF
R&D
0012J00002U6Wwu
HilleVax
522
8/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal Oct 2023: Calico Life Sciences - Vault Sub/SubA - 10 Subs; 5 SubsA Users
4. Negotiation
Q3-2024
95
9
8/31/2023
9/28/2022
Sales
Subscription
0015000001nxYfoAAE
0015000001nxYfoAAE
R&D
0015000001nxYfo
Calico Life Sciences LLC
523
8/31/2023
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal Oct 2023: Calico Life Sciences - CTMS - 40 active, 1 archive, 34 future active
4. Negotiation
Q3-2024
95
8
8/31/2023
9/29/2022
Subscription
0015000001nxYfoAAE
0015000001nxYfoAAE
R&D
0015000001nxYfo
Calico Life Sciences LLC
524
8/31/2023
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Adverum Biotechnologies, Inc.
Renewal Oct 2023: Adverum Biotechnologies - Vault Sub/SubA - 200 ELA
4. Negotiation
Q3-2024
95
8
8/31/2023
9/29/2022
Subscription
0015000000wO1vGAAS
0015000000wO1vGAAS
R&D
0015000000wO1vG
Adverum Biotechnologies, Inc.
525
8/31/2023
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal Oct 2023: Xeris - Submissions and Submissions Archive Renewal
4. Negotiation
Q3-2024
95
8
8/31/2023
9/29/2022
Subscription
00150000018Qz0AAAS
00150000018Qz0AAAS
R&D
00150000018Qz0A
Strongbridge Biopharma plc
526
8/31/2023
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal Oct 2023: Xeris - Vault Quality Renewal
4. Negotiation
Q3-2024
95
7
8/31/2023
9/30/2022
Subscription
00150000018Qz0AAAS
00150000018Qz0AAAS
R&D
00150000018Qz0A
Strongbridge Biopharma plc
527
9/4/2023
EU Sales User - R&D SMB
Charlie Williams
MeiraGTx LLC
Renewal Oct 2023: Meira GTx - CTMS - New App
4. Negotiation
Q3-2024
95
39
9/4/2023
8/29/2022
Sales
Subscription
0012J00002XRL5vQAH
0012J00002XRL5vQAH
R&D
0012J00002XRL5v
MeiraGTx LLC
528
9/4/2023
EU Sales User - R&D SMB
Charlie Williams
MeiraGTx LLC
Renewal Oct 2023: Meira GTX (New Logo) - eTMF 20 Sites
4. Negotiation
Q3-2024
95
7
9/4/2023
9/30/2022
Subscription
0012J00002XRL5vQAH
0012J00002XRL5vQAH
R&D
0012J00002XRL5v
MeiraGTx LLC
529
9/4/2023
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal Oct 2023: Myovant Sciences (SV) - Vault eTMF - 25 Active Sites
4. Negotiation
Q3-2024
95
16
9/4/2023
9/21/2022
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
530
9/5/2023
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Seres Therapeutics, Inc.
Renewal Oct 2023: Seres Therapeutics-Vault RIM, Clinical, & Quality
4. Negotiation
Q3-2024
95
8
9/5/2023
9/29/2022
Subscription
0015000000zPfrZAAS
0015000000zPfrZAAS
R&D
0015000000zPfrZ
Seres Therapeutics, Inc.
531
9/16/2023
EU Sales User - R&D ENT
Julien Bechtel
Ferring International Center SA
Ferring - QualityDocs ELA Year 3 Renewal + Ramp
Closed Won
Q3-2024
100
771
9/16/2023
8/6/2021
Renewal
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
QMS; QualityDocs
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
532
9/16/2023
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Polynoma LLC
Renewal Oct 2023: Polynoma - Vault eTMF - 75 Active to Archive Sites
4. Negotiation
Q3-2024
95
15
9/16/2023
9/22/2022
Sales
Subscription
0015000000fTTJBAA4
0015000000fTTJBAA4
R&D
0015000000fTTJB
Polynoma LLC
533
9/27/2023
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
HilleVax, Inc.
Renewal Oct 2023: HilleVax QualityDocs
4. Negotiation
Q3-2024
95
10
9/27/2023
9/27/2022
Sales
Subscription
0012J00002U6WwuQAF
0012J00002U6WwuQAF
R&D
0012J00002U6Wwu
HilleVax
534
10/1/2023
US Sales User - R&D SMB
Stephanie Griffin
Jim Thai
CytomX Therapeutics, LLC
Renewal 2023: CytomX -Vault Training 300 ELA
4. Negotiation
Q3-2024
95
142
10/1/2023
5/18/2022
Sales
Subscription
0015000000WwNKHAA3
0015000000WwNKHAA3
R&D
0015000000WwNKH
CytomX Therapeutics, LLC
535
10/1/2023
US Sales User - R&D SMB
Stephanie Griffin
Jim Thai
CytomX Therapeutics, LLC
Renewal Nov 2023: Cytomx - QDocs ELA, QMS, eTMF, RIM
4. Negotiation
Q3-2024
95
3
10/1/2023
10/4/2022
Sales
Subscription
0015000000WwNKHAA3
0015000000WwNKHAA3
R&D
0015000000WwNKH
CytomX Therapeutics, LLC
536
10/1/2023
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal Nov 2023: IAVI - NA - eTMF - Nov 2022
4. Negotiation
Q3-2024
95
3
10/1/2023
10/4/2022
Subscription
00150000019DKfQAAW
00150000019DKfQAAW
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
537
10/1/2023
US Sales User - R&D SMB
Seth Fox
David Florez
RVL Pharmaceuticals, Inc.
Renewal Nov 2023: RVL Pharmaceuticals - Vault QualityDocs - 10 Full/150 RO
4. Negotiation
Q3-2024
95
1
10/1/2023
10/6/2022
Sales
Subscription
0012J00002XP6vKQAT
0012J00002XP6vKQAT
R&D
0012J00002XP6vK
RVL Pharmaceuticals
538
10/1/2023
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
Renewal 2023: BD - CTMS, Payments. eTMF ELA year 2 ramp
4. Negotiation
Q3-2024
95
77
10/1/2023
7/22/2022
Strategy Team
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
R&D
0012J00002MKF7I
Becton, Dickinson and Company
539
10/22/2023
CN Sales User - R&D ENT
Fancy Chen
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal 2023: Dizal-China-CTMS-China Biotech ELA 250
4. Negotiation
Q3-2024
95
227
10/22/2023
2/22/2022
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
540
10/23/2023
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal 2023: Dizal-China-eTMF-China Biotech ELA 250
3. Proposal
Q3-2024
0
681
10/23/2023
11/25/2020
Renewal
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
eTMF
Vault
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
541
10/27/2023
CN Sales User - R&D SMB
Shirley Wang
Suzhou Ceclor Pharmaceutical Co., Ltd.
Renewal 2023: Ceclor-China-QMS-biotech ELA250
4. Negotiation
Q3-2024
95
345
10/27/2023
10/27/2021
Strategy Team
Subscription
0012J00002U7d2UQAR
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002U7d2U
0015000000tsIxG
Ceclor
542
10/31/2023
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Renewal 2022: Turning Point Therapeutics - CTMS - 32 Orphan Sites & 32 Non-Orphan Sites
3. Proposal
Q3-2024
70
302
10/31/2023
12/9/2021
Sales
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
543
10/31/2023
EU Sales User - R&D SMB
Rachel Mc Hugh
Sandoz S.A
Sandoz - eTMF ELA Y2
3. Proposal
Q3-2024
70
114
10/31/2023
6/15/2022
Sales
Subscription
0012J00002MJthqQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MJthq
0012J00002MIzmf
The Medicines Company
544
10/31/2023
EU Sales User - R&D SMB
Sarah Kemkes
MorphoSys AG
Renewal Dec 2023: Renewal 2022 Morphosys - RIM ELA 1000
4. Negotiation
Q3-2024
95
43
10/31/2023
8/25/2022
Sales
Subscription
0015000000OQ3L7AAL
0015000000OQ3L7AAL
R&D
0015000000OQ3L7
MorphoSys AG
545
10/31/2023
EU Sales User - R&D SMB
Rachel Mc Hugh
Sandoz S.A
Sandoz - eTMF ELA Y3
3. Proposal
Q3-2024
90
8
10/31/2023
9/29/2022
Sales
Subscription
0012J00002MJthqQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MJthq
0012J00002MIzmf
The Medicines Company
546
10/31/2023
EU Sales User - R&D SMB
Jan-Eric Bittner
MorphoSys AG
Renewal Dec 2023: MorphoSys - QMS, QDocs,Training ELA1000
4. Negotiation
Q3-2024
95
2
10/31/2023
10/5/2022
Sales
Subscription
0015000000OQ3L7AAL
0015000000OQ3L7AAL
R&D
0015000000OQ3L7
MorphoSys AG
547
11/1/2023
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2023: Vaxart - Vault QualityDocs/Training - 100 ELA
4. Negotiation
Q4-2024
95
340
11/1/2023
11/1/2021
Sales
Subscription
0015000001HesyBAAR
0015000001HesyBAAR
R&D
0015000001HesyB
Vaxart Inc
548
11/1/2023
EU Sales User - MedTech ENT
Michael Fischöder
Straumann Holding AG
Renewal 2023: Straumann - Vault QMS & Quality Base
4. Negotiation
Q4-2024
95
316
11/1/2023
11/25/2021
Sales
Subscription
0015000000nCWEZAA4
0012J00002U5C7vQAF
0012J00002U5C7vQAF
0012J00002U5C7vQAF
R&D
0015000000nCWEZ
0012J00002U5C7v
Straumann Usa, LLC
549
11/3/2023
CN Sales User - R&D SMB
Shirley Wang
Mabspace Biosciences (Suzhou) Co. LTd.
Renewal 2023: Mabspacebio-China-QualityDocs-China Biotech ELA 250
4. Negotiation
Q4-2024
95
338
11/3/2023
11/3/2021
Sales
Subscription
0012J00002Qdd40QAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002Qdd40
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
550
11/16/2023
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Dec 2023: Medytox_KR_QMS_ELA500_Year2
Closed Won
Q4-2024
100
507
11/16/2023
6/27/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
551
11/18/2023
EU Sales User - MedTech ENT
Michael Fischöder
Institut Straumann AG
Renewal 2023: Straumann - Vault QMS - period 1 - 8
Closed Won
Q4-2024
100
610
11/18/2023
3/18/2022
Sales
Subscription
0012J00002U5C7vQAF
0012J00002U5C7vQAF
R&D
0012J00002U5C7v
Straumann Usa, LLC
552
11/30/2023
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal: GSK Consumer Safety 2024
6. Awaiting P.O.
Q4-2024
99
666
11/30/2023
12/10/2020
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Vault Safety
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
553
12/1/2023
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal 2024: IAVI - eTMF 4 Archive Sites Mult-Year T002 Trial
3. Proposal
Q4-2024
0
641
12/1/2023
1/4/2021
Renewal
00150000019DKfQAAW
00150000019DKfQAAW
eTMF
Vault
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
554
12/1/2023
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
Renewal Jan 2024: Sanofi - QDocs QMS Training ELA
4. Negotiation
Q4-2024
95
28
12/1/2023
9/9/2022
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
555
12/1/2023
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal Jan 2024: Immunocore - Vault RIM
4. Negotiation
Q4-2024
95
25
12/1/2023
9/12/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
556
12/1/2023
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal Jan 2024: Immunocore - Clinical
4. Negotiation
Q4-2024
95
7
12/1/2023
9/30/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
557
12/14/2023
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2023: GSK Biopharma RIM ELA
6. Awaiting P.O.
Q4-2024
99
297
12/14/2023
12/14/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
558
12/16/2023
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2023: GSK Biopharma eTMF ELA
4. Negotiation
Q4-2024
95
295
12/16/2023
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
559
12/16/2023
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2023: GSK Biopharma CTMS ELA
4. Negotiation
Q4-2024
95
295
12/16/2023
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
560
12/30/2023
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
GSK Consumer Safety ELA 2024
5. Contracting
Q4-2024
99
38
12/30/2023
8/30/2022
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
561
1/1/2024
US Sales User - MedTech ENT
David Duffy
Boston Scientific Corporation
Boston Scientific eTMF/CTMS- Year 4 Renewal of ELA
6. Awaiting P.O.
Q4-2024
0
1231
1/1/2024
5/25/2019
Sales
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
eTMF
Vault
R&D
0015000000LVRzo
0012J00002MKhDC
Boston Scientific
562
1/4/2024
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal Feb 2024: Myovant Sciences (SV) - Vault eTMF - 25 Sites (stub)
4. Negotiation
Q4-2024
95
16
1/4/2024
9/21/2022
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
563
1/4/2024
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal Feb 2024: Myovant Sciences (SV) - Vault eTMF - 25 Active Sites
4. Negotiation
Q4-2024
95
16
1/4/2024
9/21/2022
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
564
1/28/2024
CN Sales User - R&D ENT
Fancy Chen
Shenzhen Kangzhe Biotechnology Co., Ltd.
Renewal 2024: Kangzhe-China-Subs-30 full users-Add on
3. Proposal
Q4-2024
80
252
1/28/2024
1/28/2022
Sales
Subscription
0012J00002QhJ8GQAV
0015000001TVOj2AAH
0015000001TVOj2AAH
0015000001TVOj2AAH
R&D
0012J00002QhJ8G
0015000001TVOj2
Shenzhen Kangzhe Biotechnology
565
2/14/2024
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2024: Vir Bio - Publishing - 300 submissions per year
4. Negotiation
Q1-2025
95
235
2/14/2024
2/14/2022
Sales
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
566
2/18/2024
US Sales User - MedTech ENT
David Duffy
Boston Scientific Corporation
Renewal 2024: Boston Scientfic eTMF/CTMS Year 2 of ELA Renewal
4. Negotiation
Q1-2025
95
231
2/18/2024
2/18/2022
Marketing
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
R&D
0015000000LVRzo
0012J00002MKhDC
Boston Scientific
567
3/1/2024
US Sales User - R&D ENT
Dawn Wang
Takeda Pharmaceuticals U.S.A., Inc.
Renewal: Takeda- QualityDocs - Global - Year 4
2. Discovery
Q1-2025
98
277
3/1/2024
1/3/2022
Subscription
0015000000IO28HAAT
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0015000000IO28H
0012J00002MJsv2
Shire Pharmaceuticals Inc.
568
3/1/2024
US Sales User - R&D ENT
Dawn Wang
Millennium Pharmaceuticals
Renewal 2024 : Takeda Pharma - RIM - Global ELA Year 5
4. Negotiation
Q1-2025
95
225
3/1/2024
2/24/2022
Sales
Subscription
0015000000IO1EFAA1
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0015000000IO1EF
0012J00002LPydA
Shire Pharmaceuticals Inc.
569
3/5/2024
EU Manager - MedTech Sales
Jörg Gräfe
Straumann Holding AG
Straumann - Vault QD & Vault Training Third Year +50%
3. Proposal
Q1-2025
50
487
3/5/2024
6/8/2021
Sales
Subscription
0015000000nCWEZAA4
0012J00002U5C7vQAF
0012J00002U5C7vQAF
0012J00002U5C7vQAF
QualityDocs
Vault
R&D
0015000000nCWEZ
0012J00002U5C7v
Straumann Usa, LLC
570
3/25/2024
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Renewal Apr 2024: Amylyx - QualityDocs & Training
4. Negotiation
Q1-2025
95
80
3/25/2024
7/19/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
571
3/31/2024
US Sales User - R&D ENT
Dawn Wang
Takeda Pharmaceuticals
Takeda - Safety - Global - Year 3 - FY24 Placeholder
2. Discovery
Q1-2025
25
298
3/31/2024
12/13/2021
Sales
Subscription
0012J00002MJsv2QAD
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002MJsv2
0012J00002LPydA
Shire Pharmaceuticals Inc.
572
4/5/2024
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
Renewal 2024: BD - Yr 1 RIM: Adjustment #superseding
4. Negotiation
Q1-2025
95
261
4/5/2024
1/19/2022
Sales Support
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
R&D
0012J00002MKF7I
Becton, Dickinson and Company
573
4/28/2024
EU Manager - R&D Sales
Alejandro Pina
Ecuphar NV
Renewal 2023: Ecuphar - Ph I - QMS
2. Discovery
Q1-2025
60
260
4/28/2024
1/20/2022
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
R&D
00150000019EABE
0015000001T4uzn
Ecuphar NV
574
5/27/2024
CN Sales User - R&D SMB
Shirley Wang
Suzhou Transcenta Therapeutics Co., Ltd.
Renewal Jun 2024: Transcenta suzhou-China-eTMF-ELA by study
4. Negotiation
Q2-2025
95
109
5/27/2024
6/20/2022
Sales
Subscription
0012J00002ZZ6bAQAT
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002ZZ6bA
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
575
5/31/2024
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal Jul 2024: GSK Biopharma QualityDocs ELA
4. Negotiation
Q2-2025
95
108
5/31/2024
6/21/2022
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
576
6/20/2024
CN Sales User - R&D SMB
Shirley Wang
Suzhou Transcenta Therapeutics Co., Ltd.
Renewal Jun 2024: Transcenta suzhou-China-eTMF-ELA by study
Closed Won
Q2-2025
100
731
6/20/2024
6/20/2022
Sales
Subscription
0012J00002ZZ6bAQAT
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002ZZ6bA
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
577
6/30/2024
EU Sales User - R&D ENT
Katrien Mesotten
Sanofi Aventis Groupe
2024 Renewal: Sanofi - Vault SSU ELA
3. Proposal
Q2-2025
10
1810
6/30/2024
10/23/2017
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
Study Startup
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
578
7/1/2024
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Jul 2024: Medytox_KR_QD & VT_ELA500_Year3
Closed Won
Q2-2025
100
735
7/1/2024
6/27/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
579
7/20/2024
US Sales User - R&D ENT
Greg Boudreau
Takeda Development Center Americas, Inc.
Renewal 2024: Takeda Pharma - CTMS_SSU_Payments_Site Connect - Global - ELA Year 3
Closed Won
Q2-2025
100
954
7/20/2024
12/9/2021
Sales
Subscription
0012J00002aXg5vQAC
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002aXg5v
0012J00002MJsv2
Shire Pharmaceuticals Inc.
580
8/1/2024
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal Sep 2024: Lexicon - Safety - 250 active cases
4. Negotiation
Q3-2025
95
37
8/1/2024
8/31/2022
Sales
Subscription
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
581
8/1/2024
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Renewal Sep 2024: Roche Vault Payments - Y2
4. Negotiation
Q3-2025
95
52
8/1/2024
8/16/2022
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
582
8/12/2024
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2024: BioNTech SE - eTMF, CTMS, SSU - ELA Year 1
4. Negotiation
Q3-2025
95
31
8/12/2024
9/6/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
583
8/12/2024
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2024: BioNTech SE - eTMF, CTMS, SSU- ELA Year 2
4. Negotiation
Q3-2025
95
30
8/12/2024
9/7/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
584
8/31/2024
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2024: GSK BLENREP PASS - SH 7026432
4. Negotiation
Q3-2025
95
70
8/31/2024
7/29/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
585
9/1/2024
EU Sales User - R&D SMB
Reto Flury
Ferring International Center SA
Ferring - Vault Subs/SubsA - Year 2
3. Proposal
Q3-2025
80
532
9/1/2024
4/23/2021
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
Submissions; Submissions Archive
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
586
9/16/2024
EU Sales User - R&D SMB
Reto Flury
Ferring International Center SA
Renewal 2024: Ferring - QualityDocs ELA Year 3
3. Proposal
Q3-2025
90
192
9/16/2024
3/29/2022
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
587
10/1/2024
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
Renewal 2024: BD - CTMS, Payments. eTMF ELA year 3
3. Proposal
Q3-2025
90
56
10/1/2024
8/12/2022
Strategy Team
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
R&D
0012J00002MKF7I
Becton, Dickinson and Company
588
10/27/2024
CN Sales User - R&D SMB
Shirley Wang
Suzhou Ceclor Pharmaceutical Co., Ltd.
Renewal 2024: Ceclor-China-QMS-biotech ELA250
4. Negotiation
Q3-2025
95
345
10/27/2024
10/27/2021
Strategy Team
Subscription
0012J00002U7d2UQAR
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002U7d2U
0015000000tsIxG
Ceclor
589
11/1/2024
Asia Pac Sales User - R&D SMB
Sizemore Lee
Samsung BioLogics Co., Ltd.
Renewal 2024: Samsung Biologics_KR_RIM
1. Prospecting
Q4-2025
80
102
11/1/2024
6/27/2022
Sales
Subscription
0015000001IeeNHAAZ
0015000001IeeNHAAZ
R&D
0015000001IeeNH
Samsung Bioepis
590
11/3/2024
CN Sales User - R&D SMB
Shirley Wang
Mabspace Biosciences (Suzhou) Co. LTd.
Renewal 2024: Mabspacebio-China-QualityDocs-China Biotech ELA 250
4. Negotiation
Q4-2025
95
338
11/3/2024
11/3/2021
Sales
Subscription
0012J00002Qdd40QAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002Qdd40
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
591
11/30/2024
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal: GSK Consumer Safety 2025
6. Awaiting P.O.
Q4-2025
99
491
11/30/2024
6/3/2021
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Vault Safety
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
592
12/1/2024
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal 2025: IAVI - NA -QD QMS ELA - Subs/SubsA
3. Proposal
Q4-2025
0
434
12/1/2024
7/30/2021
Renewal
00150000019DKfQAAW
00150000019DKfQAAW
eTMF
Vault
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
593
12/1/2024
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
Renewal Jan 2025: Sanofi - QDocs QMS Training ELA
4. Negotiation
Q4-2025
95
87
12/1/2024
7/12/2022
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
594
12/14/2024
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2024: GSK Biopharma RIM ELA
6. Awaiting P.O.
Q4-2025
99
297
12/14/2024
12/14/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
595
12/16/2024
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2024: GSK Biopharma eTMF ELA
4. Negotiation
Q4-2025
95
295
12/16/2024
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
596
12/16/2024
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2024: GSK Biopharma CTMS ELA
4. Negotiation
Q4-2025
95
295
12/16/2024
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
597
12/30/2024
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
GSK Consumer Safety ELA 2025
5. Contracting
Q4-2025
99
38
12/30/2024
8/30/2022
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
598
12/31/2024
US Sales User - R&D ENT
Dawn Wang
Takeda Pharmaceuticals
Takeda - Safety - Global - Year 2 - FY24 Placeholder
2. Discovery
Q4-2025
25
298
12/31/2024
12/13/2021
Sales
Subscription
0012J00002MJsv2QAD
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002MJsv2
0012J00002LPydA
Shire Pharmaceuticals Inc.
599
1/16/2025
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2025: GSK 217013 - SH - 7032206
4. Negotiation
Q4-2025
99
204
1/16/2025
3/17/2022
Partner
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
600
1/19/2025
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
Renewal 2025: BD - Yr 1 RIM: Adjustment #superseding
4. Negotiation
Q4-2025
95
261
1/19/2025
1/19/2022
Sales Support
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
R&D
0012J00002MKF7I
Becton, Dickinson and Company
601
1/28/2025
CN Sales User - R&D ENT
Fancy Chen
Shenzhen Kangzhe Biotechnology Co., Ltd.
Renewal 2025: Kangzhe-China-Subs-30 full users-Add on
3. Proposal
Q4-2025
80
252
1/28/2025
1/28/2022
Sales
Subscription
0012J00002QhJ8GQAV
0015000001TVOj2AAH
0015000001TVOj2AAH
0015000001TVOj2AAH
R&D
0012J00002QhJ8G
0015000001TVOj2
Shenzhen Kangzhe Biotechnology
602
2/18/2025
US Sales User - MedTech ENT
David Duffy
Boston Scientific Corporation
Renewal 2025: Boston Scientfic eTMF/CTMS Year 2 of ELA Renewal
4. Negotiation
Q1-2026
95
231
2/18/2025
2/18/2022
Marketing
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
R&D
0015000000LVRzo
0012J00002MKhDC
Boston Scientific
603
3/1/2025
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2023: Spark Tx - Huntington's Disease Natural History Study
4. Negotiation
Q1-2026
95
151
3/1/2025
5/9/2022
Sales
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
604
4/1/2025
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal May 2025: Allucent - Clinical Suite Study ELA 200
4. Negotiation
Q1-2026
95
23
4/1/2025
9/14/2022
Sales
Subscription
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000htJv3
Pharm-Olam International, LLC
605
5/10/2025
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2025: Dizal-China Biotech-QD+TRN-ELA250
5. Contracting
Q2-2026
99
127
5/10/2025
6/2/2022
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
606
5/27/2025
CN Sales User - R&D SMB
Shirley Wang
Suzhou Transcenta Therapeutics Co., Ltd.
Renewal Jun 2025: Transcenta suzhou-China-eTMF-ELA by study
4. Negotiation
Q2-2026
95
109
5/27/2025
6/20/2022
Sales
Subscription
0012J00002ZZ6bAQAT
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002ZZ6bA
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
607
5/27/2025
CN Sales User - R&D SMB
Shirley Wang
Suzhou Transcenta Therapeutics Co., Ltd.
Renewal Jun 2025: Transcenta suzhou-China-eTMF-ELA by study
4. Negotiation
Q2-2026
95
109
5/27/2025
6/20/2022
Sales
Subscription
0012J00002ZZ6bAQAT
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002ZZ6bA
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
608
5/31/2025
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal Jul 2025: IAVI - 5 eTMF Archive Sites
4. Negotiation
Q2-2026
95
74
5/31/2025
7/25/2022
Sales
Subscription
00150000019DKfQAAW
00150000019DKfQAAW
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
609
5/31/2025
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Jul 2025: Medytox_KR_QD & VT_ELA500
4. Negotiation
Q2-2026
95
102
5/31/2025
6/28/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
610
5/31/2025
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal Jul 2025: GSK Biopharma QualityDocs ELA
4. Negotiation
Q2-2026
95
108
5/31/2025
6/21/2022
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
611
7/1/2025
US Sales User - R&D ENT
Greg Boudreau
Takeda Pharmaceuticals
Renewal 2025: Takeda Pharma - CTMS_SSU_Payments_Site Connect - Global - ELA Year 4 - Steady state
5. Contracting
Q2-2026
99
135
7/1/2025
5/25/2022
Sales
Subscription
0012J00002MJsv2QAD
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002MJsv2
0012J00002LPydA
Shire Pharmaceuticals Inc.
612
7/23/2025
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2025: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
4. Negotiation
Q2-2026
95
45
7/23/2025
8/23/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
613
8/1/2025
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Renewal Sep 2025: Roche Vault Payments - Y2
4. Negotiation
Q3-2026
95
52
8/1/2025
8/16/2022
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
614
8/1/2025
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Renewal Sep 2025: Roche Vault Payments - Y3
4. Negotiation
Q3-2026
95
52
8/1/2025
8/16/2022
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
615
8/12/2025
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2025: BioNTech SE - eTMF, CTMS, SSU - ELA Year 1
4. Negotiation
Q3-2026
95
31
8/12/2025
9/6/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
616
8/12/2025
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2025: BioNTech SE - eTMF, CTMS, SSU- ELA Year 2
4. Negotiation
Q3-2026
95
30
8/12/2025
9/7/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
617
8/12/2025
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2025: BioNTech SE - eTMF, CTMS, SSU- ELA Year 3
4. Negotiation
Q3-2026
95
30
8/12/2025
9/7/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
618
8/26/2025
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2025: EOCPharma-China-Submission&Sub Archive-15users&2users
4. Negotiation
Q3-2026
95
11
8/26/2025
9/26/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
619
9/1/2025
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2025: Syneos - Unified Clinical - SSU, CTMS, Payments - Year 4
4. Negotiation
Q3-2026
95
11
9/1/2025
9/26/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
620
9/12/2025
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2025: GSK 217102 - SH 7032207
4. Negotiation
Q3-2026
99
204
9/12/2025
3/17/2022
Partner
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
621
10/1/2025
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
Renewal 2025: BD - CTMS, Payments. eTMF ELA
3. Proposal
Q3-2026
90
56
10/1/2025
8/12/2022
Strategy Team
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
R&D
0012J00002MKF7I
Becton, Dickinson and Company
622
10/31/2025
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Jul 2025: Medytox_KR_QMS_ELA500
4. Negotiation
Q3-2026
95
102
10/31/2025
6/27/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
623
3/1/2026
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2024: Spark Tx - Huntington's Disease Natural History Study
4. Negotiation
Q1-2027
95
151
3/1/2026
5/9/2022
Sales
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
624
6/13/2026
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Jul 2026: GSK 205868 - SH 7035673
4. Negotiation
Q2-2027
95
70
6/13/2026
7/29/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
625
6/13/2026
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Jul 2026: GSK 205868 - SH 7035673
4. Negotiation
Q2-2027
95
67
6/13/2026
8/1/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
626
8/1/2026
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Renewal Sep 2026: Roche Vault Payments - Y2
4. Negotiation
Q3-2027
95
52
8/1/2026
8/16/2022
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
627
8/12/2026
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2026: BioNTech SE - eTMF, CTMS, SSU- ELA Year 2
4. Negotiation
Q3-2027
95
30
8/12/2026
9/7/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
628
8/12/2026
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2026: BioNTech SE - eTMF, CTMS, SSU- ELA Year 3
4. Negotiation
Q3-2027
95
30
8/12/2026
9/7/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
629
12/1/2026
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2027: Novartis eTMF, Vault SSU
4. Negotiation
Q4-2027
95
65
12/1/2026
8/3/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
630
3/1/2027
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2025: Spark Tx - Huntington's Disease Natural History Study
4. Negotiation
Q1-2028
95
151
3/1/2027
5/9/2022
Sales
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
631
8/12/2027
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
Renewal Sep 2027: BioNTech SE - eTMF, CTMS, SSU- ELA Year 3
4. Negotiation
Q3-2028
95
30
8/12/2027
9/7/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
632
3/23/2028
US Sales User - CRO
Joel Evans
Syneos
Renewal Apr 2028: GSK 212914 - SH 7031212
4. Negotiation
Q1-2029
95
100
3/23/2028
6/29/2022
Partner
Subscription
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002MKPWb
Inventiv
633
3/23/2028
US Sales User - CRO
Joel Evans
Syneos
Renewal Apr 2028: GSK 214066 - SH 7031218
4. Negotiation
Q1-2029
95
91
3/23/2028
7/8/2022
Partner
Subscription
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002MKPWb
Inventiv
634
9/19/2029
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2029: GSK 218065 - SH 7029281
4. Negotiation
Q3-2030
95
17
9/19/2029
9/20/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
There are no rows in this table
Want to print your doc?
This is not the way.
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.